ID	Gene Name	Species	BBID	BIOCARTA	COG_ONTOLOGY	GOTERM_BP_DIRECT	GOTERM_CC_DIRECT	GOTERM_MF_DIRECT	INTERPRO	KEGG_PATHWAY	OMIM_DISEASE	PIR_SUPERFAMILY	SMART	UP_KEYWORDS	UP_SEQ_FEATURE
ADAMTSL4	ADAMTS like 4(ADAMTSL4)	Homo sapiens				GO:0002064~epithelial cell development,GO:0006508~proteolysis,GO:0006915~apoptotic process,GO:0030198~extracellular matrix organization,GO:0036066~protein O-linked fucosylation,GO:0043065~positive regulation of apoptotic process,	GO:0005614~interstitial matrix,GO:0005788~endoplasmic reticulum lumen,GO:0031012~extracellular matrix,	GO:0002020~protease binding,GO:0004222~metalloendopeptidase activity,GO:0005515~protein binding,GO:0008233~peptidase activity,	IPR000884:Thrombospondin, type 1 repeat,IPR010294:ADAM-TS Spacer 1,IPR010909:PLAC,		225100~Ectopia lentis, isolated, autosomal recessive,225200~Ectopia lentis et pupillae,		SM00209:TSP1,	Alternative splicing,Apoptosis,Complete proteome,Extracellular matrix,Glycoprotein,Polymorphism,Reference proteome,Repeat,Secreted,Signal,	chain:ADAMTS-like protein 4,compositionally biased region:Pro-rich,domain:PLAC,domain:TSP type-1 1,domain:TSP type-1 2,domain:TSP type-1 3,domain:TSP type-1 4,domain:TSP type-1 5,domain:TSP type-1 6,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,
ARID1A	AT-rich interaction domain 1A(ARID1A)	Homo sapiens		h_hSWI-SNFpathway:Chromatin Remodeling by hSWI/SNF ATP-dependent Complexes,h_vdrPathway:Control of Gene Expression by Vitamin D Receptor,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001843~neural tube closure,GO:0003205~cardiac chamber development,GO:0003408~optic cup formation involved in camera-type eye development,GO:0006337~nucleosome disassembly,GO:0006338~chromatin remodeling,GO:0006344~maintenance of chromatin silencing,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0016569~covalent chromatin modification,GO:0030520~intracellular estrogen receptor signaling pathway,GO:0030521~androgen receptor signaling pathway,GO:0030900~forebrain development,GO:0042766~nucleosome mobilization,GO:0042921~glucocorticoid receptor signaling pathway,GO:0043044~ATP-dependent chromatin remodeling,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048096~chromatin-mediated maintenance of transcription,GO:0055007~cardiac muscle cell differentiation,GO:0060674~placenta blood vessel development,GO:1901998~toxin transport,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016514~SWI/SNF complex,GO:0071564~npBAF complex,GO:0071565~nBAF complex,GO:0090544~BAF-type complex,	GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0016922~ligand-dependent nuclear receptor binding,GO:0031491~nucleosome binding,	IPR001606:ARID/BRIGHT DNA-binding domain,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR021906:Protein of unknown function DUF3518,		614607~Mental retardation, autosomal dominant 14,		SM00501:BRIGHT,	3D-structure,Acetylation,Alternative splicing,Chromatin regulator,Complete proteome,Direct protein sequencing,DNA-binding,Mental retardation,Methylation,Neurogenesis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:AT-rich interactive domain-containing protein 1A,compositionally biased region:Gln-rich,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Ser,domain:ARID,helix,modified residue,mutagenesis site,sequence conflict,short sequence motif:LXXLL,splice variant,strand,turn,
ARID1B	AT-rich interaction domain 1B(ARID1B)	Homo sapiens				GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0007270~neuron-neuron synaptic transmission,GO:0007399~nervous system development,GO:0016569~covalent chromatin modification,GO:0048096~chromatin-mediated maintenance of transcription,GO:0060996~dendritic spine development,GO:0097026~dendritic cell dendrite assembly,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016514~SWI/SNF complex,GO:0071565~nBAF complex,GO:0090544~BAF-type complex,	GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,	IPR001606:ARID/BRIGHT DNA-binding domain,IPR011989:Armadillo-like helical,IPR021906:Protein of unknown function DUF3518,		614562~Mental retardation, autosomal dominant 12,		SM00501:BRIGHT,	3D-structure,Acetylation,Alternative splicing,Chromatin regulator,Complete proteome,DNA-binding,Mental retardation,Methylation,Neurogenesis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Triplet repeat expansion,	chain:AT-rich interactive domain-containing protein 1B,compositionally biased region:Ala-rich,compositionally biased region:Gln-rich,compositionally biased region:Gly-rich,compositionally biased region:His-rich,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,domain:ARID,helix,modified residue,sequence conflict,sequence variant,short sequence motif:LXXLL,splice variant,
ATRX	ATRX, chromatin remodeler(ATRX)	Homo sapiens				GO:0006281~DNA repair,GO:0006306~DNA methylation,GO:0006310~DNA recombination,GO:0006334~nucleosome assembly,GO:0006336~DNA replication-independent nucleosome assembly,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007283~spermatogenesis,GO:0010571~positive regulation of nuclear cell cycle DNA replication,GO:0016569~covalent chromatin modification,GO:0030330~DNA damage response, signal transduction by p53 class mediator,GO:0030900~forebrain development,GO:0031297~replication fork processing,GO:0032206~positive regulation of telomere maintenance,GO:0032508~DNA duplex unwinding,GO:0035128~post-embryonic forelimb morphogenesis,GO:0035264~multicellular organism growth,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060009~Sertoli cell development,GO:0070198~protein localization to chromosome, telomeric region,GO:0072520~seminiferous tubule development,GO:0072711~cellular response to hydroxyurea,GO:1900112~regulation of histone H3-K9 trimethylation,GO:1901581~negative regulation of telomeric RNA transcription from RNA pol II promoter,GO:1901582~positive regulation of telomeric RNA transcription from RNA pol II promoter,GO:1904908~negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005720~nuclear heterochromatin,GO:0005721~pericentric heterochromatin,GO:0016605~PML body,GO:0031933~telomeric heterochromatin,GO:0070603~SWI/SNF superfamily-type complex,GO:1990707~nuclear subtelomeric heterochromatin,	GO:0003677~DNA binding,GO:0003678~DNA helicase activity,GO:0003682~chromatin binding,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0015616~DNA translocase activity,GO:0035064~methylated histone binding,GO:0042393~histone binding,GO:0046872~metal ion binding,GO:0070087~chromo shadow domain binding,	IPR000330:SNF2-related,IPR001650:Helicase, C-terminal,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR025766:ADD domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		300448~Alpha-thalassemia myelodysplasia syndrome, somatic,301040~Alpha-thalassemia/mental retardation syndrome,309580~Mental retardation-hypotonic facies syndrome, X-linked,Mental retardation, X-linked 52~Mental retardation, X-linked 52,		SM00487:DEXDc,SM00490:HELICc,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Chromatin regulator,Chromosome,Coiled coil,Complete proteome,Disease mutation,DNA damage,DNA repair,DNA-binding,Helicase,Hydrolase,Isopeptide bond,Mental retardation,Metal-binding,Methylation,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Telomere,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Transcriptional regulator ATRX,compositionally biased region:Poly-Asp,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Lys,compositionally biased region:Poly-Ser,domain:Helicase ATP-binding,domain:Helicase C-terminal,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEGH box,short sequence motif:PxVxL motif,splice variant,strand,turn,zinc finger region:GATA-type; atypical,zinc finger region:PHD-type,
BCL9L	B-cell CLL/lymphoma 9-like(BCL9L)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0022604~regulation of cell morphogenesis,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0035019~somatic stem cell population maintenance,GO:0035914~skeletal muscle cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060070~canonical Wnt signaling pathway,GO:1904837~beta-catenin-TCF complex assembly,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,	GO:0003713~transcription coactivator activity,GO:0008013~beta-catenin binding,	IPR015668:B Cell Lymphoma 9,IPR024670:B-cell lymphoma 9, beta-catenin binding domain,					3D-structure,Acetylation,Activator,Alternative splicing,Complete proteome,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:B-cell CLL/lymphoma 9-like protein,compositionally biased region:Met-rich,compositionally biased region:Pro-rich,modified residue,region of interest:Necessary for interaction with CTNNB1,splice variant,
BCORL1	BCL6 corepressor-like 1(BCORL1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016569~covalent chromatin modification,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005886~plasma membrane,		IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	3D-structure,Alternative splicing,ANK repeat,Chromatin regulator,Complete proteome,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:BCL-6 corepressor-like protein 1,compositionally biased region:Pro-rich,modified residue,mutagenesis site,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,
BRCA2	BRCA2, DNA repair associated(BRCA2)	Homo sapiens		h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,		GO:0000722~telomere maintenance via recombination,GO:0000724~double-strand break repair via homologous recombination,GO:0000731~DNA synthesis involved in DNA repair,GO:0000732~strand displacement,GO:0000910~cytokinesis,GO:0001556~oocyte maturation,GO:0001833~inner cell mass cell proliferation,GO:0006289~nucleotide-excision repair,GO:0006302~double-strand break repair,GO:0006978~DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,GO:0007141~male meiosis I,GO:0007283~spermatogenesis,GO:0007420~brain development,GO:0007569~cell aging,GO:0008585~female gonad development,GO:0010165~response to X-ray,GO:0010225~response to UV-C,GO:0010332~response to gamma radiation,GO:0030097~hemopoiesis,GO:0031052~chromosome breakage,GO:0032465~regulation of cytokinesis,GO:0033600~negative regulation of mammary gland epithelial cell proliferation,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0043966~histone H3 acetylation,GO:0043967~histone H4 acetylation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045931~positive regulation of mitotic cell cycle,GO:0048478~replication fork protection,GO:0051298~centrosome duplication,GO:0070200~establishment of protein localization to telomere,GO:1990426~mitotic recombination-dependent replication fork processing,	GO:0000784~nuclear chromosome, telomeric region,GO:0000800~lateral element,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0016021~integral component of membrane,GO:0030141~secretory granule,GO:0033593~BRCA2-MAGE-D1 complex,GO:0043234~protein complex,	GO:0002020~protease binding,GO:0003697~single-stranded DNA binding,GO:0004402~histone acetyltransferase activity,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0010484~H3 histone acetyltransferase activity,GO:0010485~H4 histone acetyltransferase activity,GO:0043015~gamma-tubulin binding,	IPR002093:BRCA2 repeat,IPR012340:Nucleic acid-binding, OB-fold,IPR015187:BRCA2, oligonucleotide/oligosaccharide-binding 1,IPR015188:BRCA2, oligonucleotide/oligosaccharide-binding 3,IPR015205:Tower,IPR015252:DNA recombination/repair protein BRCA2, helical domain,IPR015525:Breast cancer type 2 susceptibility protein,	hsa03440:Homologous recombination,hsa03460:Fanconi anemia pathway,hsa05200:Pathways in cancer,hsa05212:Pancreatic cancer,	114480~Breast cancer, male, susceptibility to,155255~Medulloblastoma,176807~Prostate cancer,194070~Wilms tumor,605724~Fanconi anemia, complementation group D1,612555~Breast-ovarian cancer, familial, 2,613029~Glioblastoma 3,613347~Pancreatic cancer 2,	PIRSF002397:DNA recombination repair protein, BRCA2 type,	SM01341:SM01341,	3D-structure,Cell cycle,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,DNA damage,DNA recombination,DNA repair,DNA-binding,Fanconi anemia,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Tumor suppressor,Ubl conjugation,	chain:Breast cancer type 2 susceptibility protein,helix,modified residue,region of interest:Interaction with FANCD2,region of interest:Interaction with PALB2,repeat:BRCA2 1,repeat:BRCA2 2,repeat:BRCA2 3,repeat:BRCA2 4,repeat:BRCA2 5,repeat:BRCA2 6,repeat:BRCA2 7,repeat:BRCA2 8,sequence conflict,sequence variant,turn,
BTBD7	BTB domain containing 7(BTBD7)	Homo sapiens				GO:0007275~multicellular organism development,GO:0060693~regulation of branching involved in salivary gland morphogenesis,	GO:0005634~nucleus,		IPR000210:BTB/POZ-like,IPR011333:BTB/POZ fold,IPR011705:BTB/Kelch-associated,				SM00225:BTB,SM00875:SM00875,	Alternative splicing,Complete proteome,Developmental protein,Lipoprotein,Myristate,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:BTB/POZ domain-containing protein 7,compositionally biased region:Poly-Ala,compositionally biased region:Pro-rich,domain:BTB 1,domain:BTB 2,modified residue,sequence conflict,splice variant,
FBXW7	F-box and WD repeat domain containing 7(FBXW7)	Homo sapiens		h_fbw7Pathway:Cyclin E Destruction Pathway,		GO:0000209~protein polyubiquitination,GO:0001944~vasculature development,GO:0006974~cellular response to DNA damage stimulus,GO:0007062~sister chromatid cohesion,GO:0010868~negative regulation of triglyceride biosynthetic process,GO:0010883~regulation of lipid storage,GO:0016032~viral process,GO:0016567~protein ubiquitination,GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,GO:0031398~positive regulation of protein ubiquitination,GO:0032876~negative regulation of DNA endoreduplication,GO:0032880~regulation of protein localization,GO:0034644~cellular response to UV,GO:0045741~positive regulation of epidermal growth factor-activated receptor activity,GO:0045746~negative regulation of Notch signaling pathway,GO:0050821~protein stabilization,GO:0051443~positive regulation of ubiquitin-protein transferase activity,GO:0055088~lipid homeostasis,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:1901800~positive regulation of proteasomal protein catabolic process,GO:1902806~regulation of cell cycle G1/S phase transition,GO:1903146~regulation of mitophagy,GO:1903378~positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,GO:1903955~positive regulation of protein targeting to mitochondrion,GO:2000060~positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:2000346~negative regulation of hepatocyte proliferation,GO:2000639~negative regulation of SREBP signaling pathway,	GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0019005~SCF ubiquitin ligase complex,GO:0043234~protein complex,GO:1990452~Parkin-FBXW7-Cul1 ubiquitin ligase complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0030332~cyclin binding,GO:0030674~protein binding, bridging,GO:0031625~ubiquitin protein ligase binding,GO:0042802~identical protein binding,GO:0050816~phosphothreonine binding,GO:0097027~ubiquitin-protein transferase activator activity,	IPR001680:WD40 repeat,IPR001810:F-box domain, cyclin-like,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,	hsa04120:Ubiquitin mediated proteolysis,			SM00256:FBOX,SM00320:WD40,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Host-virus interaction,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Ubl conjugation,Ubl conjugation pathway,WD repeat,	chain:F-box/WD repeat-containing protein 7,domain:F-box,helix,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence conflict,sequence variant,splice variant,strand,turn,
GCC2	GRIP and coiled-coil domain containing 2(GCC2)	Homo sapiens				GO:0000042~protein targeting to Golgi,GO:0006622~protein targeting to lysosome,GO:0031023~microtubule organizing center organization,GO:0034067~protein localization to Golgi apparatus,GO:0034453~microtubule anchoring,GO:0034499~late endosome to Golgi transport,GO:0042147~retrograde transport, endosome to Golgi,GO:0043001~Golgi to plasma membrane protein transport,GO:0070861~regulation of protein exit from endoplasmic reticulum,GO:0071955~recycling endosome to Golgi transport,GO:0090161~Golgi ribbon formation,	GO:0005622~intracellular,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0016020~membrane,	GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR000237:GRIP,				SM00755:Grip,	3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Golgi apparatus,Membrane,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:GRIP and coiled-coil domain-containing protein 2,compositionally biased region:Glu-rich,domain:GRIP,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,
IWS1	IWS1, SUPT6H interacting protein(IWS1)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0010793~regulation of mRNA export from nucleus,GO:0032784~regulation of DNA-templated transcription, elongation,GO:0050684~regulation of mRNA processing,GO:0051028~mRNA transport,GO:0090239~regulation of histone H4 acetylation,GO:2001253~regulation of histone H3-K36 trimethylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003677~DNA binding,GO:0005515~protein binding,	IPR017923:Transcription factor IIS, N-terminal,					Acetylation,Alternative splicing,Complete proteome,mRNA processing,mRNA splicing,mRNA transport,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Transport,	chain:Protein IWS1 homolog,compositionally biased region:Glu-rich,domain:TFIIS N-terminal,modified residue,region of interest:3 X approximate tandem repeats,repeat:1,repeat:2,repeat:3; half-length,sequence conflict,sequence variant,splice variant,
LARP1	La ribonucleoprotein domain family member 1(LARP1)	Homo sapiens			Posttranslational modification, protein turnover, chaperones / Translation, ribosomal structure and biogenesis,	GO:0006413~translational initiation,GO:0008283~cell proliferation,GO:0016239~positive regulation of macroautophagy,GO:0031929~TOR signaling,GO:0045070~positive regulation of viral genome replication,GO:0045727~positive regulation of translation,GO:0098609~cell-cell adhesion,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0031931~TORC1 complex,	GO:0000339~RNA cap binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0008190~eukaryotic initiation factor 4E binding,GO:0008494~translation activator activity,GO:0031369~translation initiation factor binding,GO:0044822~poly(A) RNA binding,GO:0048027~mRNA 5'-UTR binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR006607:Protein of unknown function DM15,IPR006630:RNA-binding protein Lupus La,IPR011991:Winged helix-turn-helix DNA-binding domain,				SM00684:DM15,SM00715:LA,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Isopeptide bond,Methylation,Phosphoprotein,Protein biosynthesis,Proteomics identification,Reference proteome,RNA-binding,Ubl conjugation,	chain:La-related protein 1,compositionally biased region:Poly-Gly,domain:HTH La-type RNA-binding,modified residue,sequence conflict,splice variant,
LARP4B	La ribonucleoprotein domain family member 4B(LARP4B)	Homo sapiens				GO:0045727~positive regulation of translation,	GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,GO:0042788~polysomal ribosome,	GO:0000166~nucleotide binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR006630:RNA-binding protein Lupus La,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00715:LA,	3D-structure,Acetylation,Complete proteome,Cytoplasm,Methylation,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Translation regulation,	chain:La-related protein 4B,domain:HTH La-type RNA-binding,domain:RRM,modified residue,
MGA	MGA, MAX dimerization protein(MGA)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0071339~MLL1 complex,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0046983~protein dimerization activity,	IPR001699:Transcription factor, T-box,IPR008967:p53-like transcription factor, DNA-binding,IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,IPR018186:Transcription factor, T-box, conserved site,				SM00353:HLH,SM00425:TBOX,	Alternative splicing,Coiled coil,Complete proteome,DNA-binding,Isopeptide bond,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:MAX gene-associated protein,compositionally biased region:Gln-rich,compositionally biased region:Poly-Ser,compositionally biased region:Thr-rich,DNA-binding region:Basic motif,DNA-binding region:T-box,domain:Helix-loop-helix motif,modified residue,sequence conflict,sequence variant,splice variant,
MIS18BP1	MIS18 binding protein 1(MIS18BP1)	Homo sapiens				GO:0007067~mitotic nuclear division,GO:0034080~CENP-A containing nucleosome assembly,GO:0051301~cell division,	GO:0000778~condensed nuclear chromosome kinetochore,GO:0005654~nucleoplasm,	GO:0003677~DNA binding,GO:0005515~protein binding,	IPR001005:SANT/Myb domain,IPR009057:Homeodomain-like,IPR015216:SANT associated,IPR017884:SANT domain,				SM00717:SANT,	3D-structure,Alternative splicing,Cell cycle,Cell division,Centromere,Chromosome,Complete proteome,DNA-binding,Isopeptide bond,Mitosis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Kinetochore-associated protein KNL-2 homolog,compositionally biased region:Poly-Asp,domain:SANT,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
PDS5B	PDS5 cohesin associated factor B(PDS5B)	Homo sapiens				GO:0006281~DNA repair,GO:0007062~sister chromatid cohesion,GO:0007064~mitotic sister chromatid cohesion,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0042127~regulation of cell proliferation,GO:0051301~cell division,	GO:0000775~chromosome, centromeric region,GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005829~cytosol,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,					3D-structure,Acetylation,Alternative splicing,Cell cycle,Cell division,Complete proteome,Mitosis,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:Sister chromatid cohesion protein PDS5 homolog B,DNA-binding region:A.T hook 1,DNA-binding region:A.T hook 2,DNA-binding region:A.T hook 3,modified residue,repeat:HEAT,sequence conflict,splice variant,
PHF14	PHD finger protein 14(PHF14)	Homo sapiens			General function prediction only,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0048286~lung alveolus development,GO:2000584~negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,GO:2000791~negative regulation of mesenchymal cell proliferation involved in lung development,	GO:0005634~nucleus,	GO:0008270~zinc ion binding,	IPR001965:Zinc finger, PHD-type,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,				SM00249:PHD,	Alternative initiation,Alternative splicing,Coiled coil,Complete proteome,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:PHD finger protein 14,compositionally biased region:Glu/Lys-rich,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:PHD-type 1,zinc finger region:PHD-type 2,
RASA1	RAS p21 protein activator 1(RASA1)	Homo sapiens		h_egfPathway:EGF Signaling Pathway,h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_igf1Pathway:IGF-1 Signaling Pathway,h_insulinPathway:Insulin Signaling Pathway,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,h_pdgfPathway:PDGF Signaling Pathway,h_sam68Pathway:Regulation of Splicing through Sam68,h_spryPathway:Sprouty regulation of tyrosine kinase signals,h_tcrPathway:T Cell Receptor Signaling Pathway,h_tpoPathway:TPO Signaling Pathway,		GO:0000165~MAPK cascade,GO:0000281~mitotic cytokinesis,GO:0001570~vasculogenesis,GO:0001953~negative regulation of cell-matrix adhesion,GO:0007162~negative regulation of cell adhesion,GO:0007165~signal transduction,GO:0008360~regulation of cell shape,GO:0009790~embryo development,GO:0030833~regulation of actin filament polymerization,GO:0035556~intracellular signal transduction,GO:0043524~negative regulation of neuron apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0046580~negative regulation of Ras protein signal transduction,GO:0048013~ephrin receptor signaling pathway,GO:0048514~blood vessel morphogenesis,GO:0051252~regulation of RNA metabolic process,	GO:0001726~ruffle,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0031235~intrinsic component of the cytoplasmic side of the plasma membrane,	GO:0001948~glycoprotein binding,GO:0005096~GTPase activator activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0019870~potassium channel inhibitor activity,GO:0051020~GTPase binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR000980:SH2 domain,IPR001452:Src homology-3 domain,IPR001849:Pleckstrin homology domain,IPR001936:Ras GTPase-activating protein,IPR008936:Rho GTPase activation protein,IPR011993:Pleckstrin homology-like domain,IPR023152:Ras GTPase-activating protein, conserved site,	hsa04010:MAPK signaling pathway,hsa04014:Ras signaling pathway,hsa04360:Axon guidance,	605462~Basal cell carcinoma, somatic,608354~Capillary malformation-arteriovenous malformation,608355~Parkes Weber syndrome,		SM00233:PH,SM00239:C2,SM00252:SH2,SM00323:RasGAP,SM00326:SH3,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,GTPase activation,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,SH2 domain,SH3 domain,Tumor suppressor,	chain:Ras GTPase-activating protein 1,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Pro,domain:C2,domain:PH,domain:Ras-GAP,domain:SH2 1,domain:SH2 2,domain:SH3,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
RB1	RB transcriptional corepressor 1(RB1)	Homo sapiens	94.E2F_transcriptional_activity_cell_cycle,	h_arfPathway:Tumor Suppressor Arf Inhibits Ribosomal Biogenesis,h_btg2Pathway:BTG family proteins and cell cycle regulation,h_cellcyclePathway:Cyclins and Cell Cycle Regulation,h_fasPathway:FAS signaling pathway ( CD95 ),h_fbw7Pathway:Cyclin E Destruction Pathway,h_g1Pathway:Cell Cycle: G1/S Check Point ,h_hcmvPathway:Human Cytomegalovirus and Map Kinase Pathways,h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_p27Pathway:Regulation of p27 Phosphorylation during Cell Cycle Progression,h_p53Pathway:p53 Signaling Pathway,h_pmlPathway:Regulation of transcriptional activity by PML,h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),h_raccycdPathway:Influence of Ras and Rho proteins on G1 to S Transition,h_rbPathway:RB Tumor Suppressor/Checkpoint Signaling in response to DNA damage,h_skp2e2fPathway:E2F1 Destruction Pathway,h_telPathway:Telomeres, Telomerase, Cellular Aging, and  Immortality,h_tercPathway:Overview of telomerase RNA component gene hTerc Transcriptional Regulation,h_tidPathway:Chaperones modulate interferon Signaling Pathway,h_tnfr1Pathway:TNFR1 Signaling Pathway,		GO:0000075~cell cycle checkpoint,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000083~regulation of transcription involved in G1/S transition of mitotic cell cycle,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001558~regulation of cell growth,GO:0001894~tissue homeostasis,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006469~negative regulation of protein kinase activity,GO:0006915~apoptotic process,GO:0007050~cell cycle arrest,GO:0007070~negative regulation of transcription from RNA polymerase II promoter during mitosis,GO:0007093~mitotic cell cycle checkpoint,GO:0007265~Ras protein signal transduction,GO:0007346~regulation of mitotic cell cycle,GO:0008285~negative regulation of cell proliferation,GO:0010629~negative regulation of gene expression,GO:0016032~viral process,GO:0016569~covalent chromatin modification,GO:0030521~androgen receptor signaling pathway,GO:0031134~sister chromatid biorientation,GO:0031175~neuron projection development,GO:0034088~maintenance of mitotic sister chromatid cohesion,GO:0034349~glial cell apoptotic process,GO:0035914~skeletal muscle cell differentiation,GO:0042551~neuron maturation,GO:0043353~enucleate erythrocyte differentiation,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0043550~regulation of lipid kinase activity,GO:0045445~myoblast differentiation,GO:0045651~positive regulation of macrophage differentiation,GO:0045842~positive regulation of mitotic metaphase/anaphase transition,GO:0045879~negative regulation of smoothened signaling pathway,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048565~digestive tract development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0051146~striated muscle cell differentiation,GO:0051301~cell division,GO:0051402~neuron apoptotic process,GO:0051726~regulation of cell cycle,GO:0071459~protein localization to chromosome, centromeric region,GO:0071466~cellular response to xenobiotic stimulus,GO:0071922~regulation of cohesin loading,GO:0071930~negative regulation of transcription involved in G1/S transition of mitotic cell cycle,GO:0090230~regulation of centromere complex assembly,GO:0097284~hepatocyte apoptotic process,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,GO:2000679~positive regulation of transcription regulatory region DNA binding,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005819~spindle,GO:0008024~cyclin/CDK positive transcription elongation factor complex,GO:0016514~SWI/SNF complex,GO:0016605~PML body,GO:0035189~Rb-E2F complex,	GO:0001047~core promoter binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019900~kinase binding,GO:0031625~ubiquitin protein ligase binding,GO:0042802~identical protein binding,GO:0050681~androgen receptor binding,GO:0051219~phosphoprotein binding,	IPR002719:Retinoblastoma-associated protein, B-box,IPR002720:Retinoblastoma-associated protein, A-box,IPR013763:Cyclin-like,IPR015030:Rb C-terminal,IPR024599:Domain of unknown function DUF3452, retinoblastoma-associated,	hsa04110:Cell cycle,hsa05161:Hepatitis B,hsa05166:HTLV-I infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05212:Pancreatic cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,	109800~Bladder cancer, somatic,180200~Retinoblastoma,180200~Retinoblastoma, trilateral,182280~Small cell cancer of the lung, somatic,259500~Osteosarcoma, somatic,		SM00385:CYCLIN,SM01367:SM01367,SM01368:SM01368,SM01369:SM01369,	3D-structure,Acetylation,Cell cycle,Chromatin regulator,Complete proteome,Direct protein sequencing,Disease mutation,DNA-binding,Host-virus interaction,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Tumor suppressor,	chain:Retinoblastoma-associated protein,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Pro,helix,modified residue,mutagenesis site,region of interest:Domain A,region of interest:Domain B,region of interest:Domain C; mediates interaction with E4F1,region of interest:Interaction with LIMD1,region of interest:Pocket; binds T and E1A,region of interest:Spacer,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,strand,turn,
RBM6	RNA binding motif protein 6(RBM6)	Homo sapiens			Function unknown,	GO:0006396~RNA processing,	GO:0005634~nucleus,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000467:G-patch domain,IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,SM00443:G_patch,	Alternative splicing,Coiled coil,Complete proteome,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,Ubl conjugation,	chain:RNA-binding protein 6,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Pro,domain:G-patch,domain:RRM,modified residue,sequence conflict,sequence variant,
ARHGAP35	Rho GTPase activating protein 35(ARHGAP35)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001843~neural tube closure,GO:0006351~transcription, DNA-templated,GO:0007264~small GTPase mediated signal transduction,GO:0007411~axon guidance,GO:0007413~axonal fasciculation,GO:0008064~regulation of actin polymerization or depolymerization,GO:0008360~regulation of cell shape,GO:0010976~positive regulation of neuron projection development,GO:0016477~cell migration,GO:0021955~central nervous system neuron axonogenesis,GO:0030879~mammary gland development,GO:0030900~forebrain development,GO:0030950~establishment or maintenance of actin cytoskeleton polarity,GO:0031668~cellular response to extracellular stimulus,GO:0032956~regulation of actin cytoskeleton organization,GO:0035024~negative regulation of Rho protein signal transduction,GO:0043010~camera-type eye development,GO:0043116~negative regulation of vascular permeability,GO:0043547~positive regulation of GTPase activity,GO:0044319~wound healing, spreading of cells,GO:0045724~positive regulation of cilium assembly,GO:0045892~negative regulation of transcription, DNA-templated,GO:0050770~regulation of axonogenesis,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0097485~neuron projection guidance,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,GO:0036064~ciliary basal body,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003714~transcription corepressor activity,GO:0005096~GTPase activator activity,GO:0005525~GTP binding,GO:0005543~phospholipid binding,	IPR000198:Rho GTPase-activating protein domain,IPR001806:Small GTPase superfamily,IPR002713:FF domain,IPR008936:Rho GTPase activation protein,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04510:Focal adhesion,hsa04611:Platelet activation,hsa04670:Leukocyte transendothelial migration,hsa04810:Regulation of actin cytoskeleton,			SM00324:RhoGAP,SM00441:FF,	3D-structure,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,DNA-binding,GTPase activation,Membrane,Nucleus,Phosphoprotein,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,	chain:Glucocorticoid receptor DNA-binding factor 1,compositionally biased region:Pro-rich,domain:FF 1,domain:FF 2,domain:FF 3,domain:FF 4,domain:Rho-GAP,helix,modified residue,sequence conflict,splice variant,strand,turn,
SETD2	SET domain containing 2(SETD2)	Homo sapiens				GO:0001525~angiogenesis,GO:0001763~morphogenesis of a branching structure,GO:0001843~neural tube closure,GO:0006298~mismatch repair,GO:0006355~regulation of transcription, DNA-templated,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0010793~regulation of mRNA export from nucleus,GO:0030900~forebrain development,GO:0034728~nucleosome organization,GO:0035441~cell migration involved in vasculogenesis,GO:0048332~mesoderm morphogenesis,GO:0048701~embryonic cranial skeleton morphogenesis,GO:0048864~stem cell development,GO:0060039~pericardium development,GO:0060669~embryonic placenta morphogenesis,GO:0060977~coronary vasculature morphogenesis,GO:0097198~histone H3-K36 trimethylation,GO:0097676~histone H3-K36 dimethylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,	GO:0005515~protein binding,GO:0018024~histone-lysine N-methyltransferase activity,GO:0046975~histone methyltransferase activity (H3-K36 specific),	IPR001202:WW domain,IPR001214:SET domain,IPR003616:Post-SET domain,IPR006560:AWS,IPR009078:Ferritin-like superfamily,IPR013257:SRI, Set2 Rpb1 interacting,	hsa00310:Lysine degradation,			SM00317:SET,SM00456:WW,SM00508:PostSET,SM00570:AWS,	3D-structure,Activator,Alternative splicing,Autism spectrum disorder,Chromatin regulator,Chromosome,Coiled coil,Complete proteome,Isopeptide bond,Mental retardation,Methyltransferase,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,S-adenosyl-L-methionine,Transcription,Transcription regulation,Transferase,Ubl conjugation,	chain:Histone-lysine N-methyltransferase SETD2,compositionally biased region:Arg-rich,compositionally biased region:Gln-rich,compositionally biased region:Pro-rich,domain:AWS,domain:Post-SET,domain:SET,domain:WW,helix,modified residue,mutagenesis site,region of interest:Interaction with POLR2A,region of interest:Low charge region,sequence conflict,sequence variant,splice variant,strand,turn,
SIN3A	SIN3 transcription regulator family member A(SIN3A)	Homo sapiens		h_etsPathway:METS affect on Macrophage Differentiation,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001701~in utero embryonic development,GO:0002218~activation of innate immune response,GO:0002230~positive regulation of defense response to virus by host,GO:0002244~hematopoietic progenitor cell differentiation,GO:0006260~DNA replication,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006476~protein deacetylation,GO:0007568~aging,GO:0010817~regulation of hormone levels,GO:0010971~positive regulation of G2/M transition of mitotic cell cycle,GO:0016575~histone deacetylation,GO:0031937~positive regulation of chromatin silencing,GO:0034613~cellular protein localization,GO:0042754~negative regulation of circadian rhythm,GO:0043066~negative regulation of apoptotic process,GO:0043619~regulation of transcription from RNA polymerase II promoter in response to oxidative stress,GO:0044255~cellular lipid metabolic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048511~rhythmic process,GO:0051595~response to methylglyoxal,GO:0071333~cellular response to glucose stimulus,GO:1900181~negative regulation of protein localization to nucleus,GO:1901675~negative regulation of histone H3-K27 acetylation,GO:1903351~cellular response to dopamine,GO:2000678~negative regulation of transcription regulatory region DNA binding,	GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016580~Sin3 complex,GO:0017053~transcriptional repressor complex,GO:0045171~intercellular bridge,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0001103~RNA polymerase II repressing transcription factor binding,GO:0001106~RNA polymerase II transcription corepressor activity,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003723~RNA binding,GO:0004407~histone deacetylase activity,GO:0005515~protein binding,GO:0032403~protein complex binding,GO:0033558~protein deacetylase activity,	IPR003822:Paired amphipathic helix,IPR013194:Histone deacetylase interacting,	hsa04919:Thyroid hormone signaling pathway,hsa05016:Huntington's disease,hsa05202:Transcriptional misregulation in cancer,			SM00761:HDAC_interact,	3D-structure,Acetylation,Biological rhythms,Coiled coil,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:Paired amphipathic helix protein Sin3a,modified residue,region of interest:Interaction with HCFC1,region of interest:Interaction with NCOR1,region of interest:Interaction with REST,region of interest:Interaction with SAP30,region of interest:Interactions with HDAC1 and ARID4B,region of interest:Interactions with SUDS3 and SAP130,repeat:PAH 1,repeat:PAH 2,repeat:PAH 3,sequence conflict,sequence variant,
SRGAP3	SLIT-ROBO Rho GTPase activating protein 3(SRGAP3)	Homo sapiens				GO:0007165~signal transduction,GO:0030336~negative regulation of cell migration,GO:0043547~positive regulation of GTPase activity,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0048365~Rac GTPase binding,	IPR000198:Rho GTPase-activating protein domain,IPR001060:FCH domain,IPR001452:Src homology-3 domain,IPR008936:Rho GTPase activation protein,	hsa04360:Axon guidance,			SM00055:FCH,SM00324:RhoGAP,SM00326:SH3,	Alternative splicing,Chromosomal rearrangement,Coiled coil,Complete proteome,GTPase activation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH3 domain,	chain:SLIT-ROBO Rho GTPase-activating protein 3,domain:FCH,domain:Rho-GAP,domain:SH3,modified residue,sequence variant,splice variant,
SCAF4	SR-related CTD associated factor 4(SCAF4)	Homo sapiens					GO:0005654~nucleoplasm,	GO:0000166~nucleotide binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR006569:CID domain,IPR006903:RNA polymerase II-binding domain,IPR008942:ENTH/VHS,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,SM00582:RPR,	Acetylation,Alternative splicing,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,RNA-binding,	chain:Splicing factor, arginine/serine-rich 15,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Pro,domain:CID,domain:RRM,modified residue,sequence conflict,sequence variant,splice variant,
TTK	TTK protein kinase(TTK)	Homo sapiens				GO:0007051~spindle organization,GO:0007052~mitotic spindle organization,GO:0007093~mitotic cell cycle checkpoint,GO:0007094~mitotic spindle assembly checkpoint,GO:0008284~positive regulation of cell proliferation,GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation,GO:0016321~female meiosis chromosome segregation,GO:0018105~peptidyl-serine phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0033316~meiotic spindle assembly checkpoint,GO:0034501~protein localization to kinetochore,GO:0046777~protein autophosphorylation,GO:0051304~chromosome separation,GO:1903096~protein localization to meiotic spindle midzone,	GO:0000776~kinetochore,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0016020~membrane,	GO:0004674~protein serine/threonine kinase activity,GO:0004712~protein serine/threonine/tyrosine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0042803~protein homodimerization activity,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR011990:Tetratricopeptide-like helical,IPR017441:Protein kinase, ATP binding site,IPR027084:Dual specificity protein kinase TTK,	hsa04110:Cell cycle,			SM00220:S_TKc,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Kinase,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Dual specificity protein kinase TTK,domain:Protein kinase,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,strand,turn,
WAC	WW domain containing adaptor with coiled-coil(WAC)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0010390~histone monoubiquitination,GO:0016239~positive regulation of macroautophagy,GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0044783~G1 DNA damage checkpoint,GO:0045893~positive regulation of transcription, DNA-templated,GO:0071894~histone H2B conserved C-terminal lysine ubiquitination,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0016607~nuclear speck,	GO:0000993~RNA polymerase II core binding,GO:0003682~chromatin binding,GO:0005515~protein binding,	IPR001202:WW domain,				SM00456:WW,	Acetylation,Alternative splicing,Chromatin regulator,Coiled coil,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:WW domain-containing adapter protein with coiled-coil,domain:WW,modified residue,sequence conflict,sequence variant,splice variant,
WT1	Wilms tumor 1(WT1)	Homo sapiens		h_tertPathway:Overview of telomerase protein component gene hTert Transcriptional Regulation ,h_tidPathway:Chaperones modulate interferon Signaling Pathway,	General function prediction only,Transcription / Cell division and chromosome partitioning,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001570~vasculogenesis,GO:0001657~ureteric bud development,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001822~kidney development,GO:0003156~regulation of organ formation,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007281~germ cell development,GO:0007356~thorax and anterior abdomen determination,GO:0007507~heart development,GO:0007530~sex determination,GO:0008285~negative regulation of cell proliferation,GO:0008380~RNA splicing,GO:0008406~gonad development,GO:0008584~male gonad development,GO:0009888~tissue development,GO:0017148~negative regulation of translation,GO:0030308~negative regulation of cell growth,GO:0030325~adrenal gland development,GO:0030539~male genitalia development,GO:0030855~epithelial cell differentiation,GO:0032835~glomerulus development,GO:0032836~glomerular basement membrane development,GO:0035802~adrenal cortex formation,GO:0043010~camera-type eye development,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060231~mesenchymal to epithelial transition,GO:0060421~positive regulation of heart growth,GO:0060539~diaphragm development,GO:0060923~cardiac muscle cell fate commitment,GO:0061032~visceral serous pericardium development,GO:0071320~cellular response to cAMP,GO:0071371~cellular response to gonadotropin stimulus,GO:0072075~metanephric mesenchyme development,GO:0072112~glomerular visceral epithelial cell differentiation,GO:0072166~posterior mesonephric tubule development,GO:0072207~metanephric epithelium development,GO:0072284~metanephric S-shaped body morphogenesis,GO:0072302~negative regulation of metanephric glomerular mesangial cell proliferation,GO:2000020~positive regulation of male gonad development,GO:2000195~negative regulation of female gonad development,GO:2001076~positive regulation of metanephric ureteric bud development,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016607~nuclear speck,	GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0010385~double-stranded methylated DNA binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0044729~hemi-methylated DNA-binding,GO:0046872~metal ion binding,GO:0070742~C2H2 zinc finger domain binding,	IPR000976:Wilm's tumour protein, N-terminal,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,IPR017987:Wilm's tumour protein,	hsa05202:Transcriptional misregulation in cancer,	136680~Frasier syndrome,156240~Mesothelioma, somatic,194070~Wilms tumor, type 1,194080~Denys-Drash syndrome,256370~Nephrotic syndrome, type 4,608978~Meacham syndrome,		SM00355:ZnF_C2H2,	3D-structure,Alternative initiation,Alternative splicing,Chromosomal rearrangement,Complete proteome,Cytoplasm,Disease mutation,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Proteomics identification,Reference proteome,Repeat,RNA editing,RNA-binding,Signal,Transcription,Transcription regulation,Tumor suppressor,Ubl conjugation,Zinc,Zinc-finger,	chain:Wilms tumor protein,compositionally biased region:Pro-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),helix,mutagenesis site,region of interest:Important for interaction with target DNA,sequence conflict,sequence variant,short sequence motif:KTS motif,site:Important for interaction with target DNA,splice variant,strand,turn,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,
YTHDC2	YTH domain containing 2(YTHDC2)	Homo sapiens				GO:0006396~RNA processing,GO:0034612~response to tumor necrosis factor,GO:0044829~positive regulation by host of viral genome replication,GO:0070555~response to interleukin-1,	GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,	GO:0003676~nucleic acid binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008186~RNA-dependent ATPase activity,GO:0044822~poly(A) RNA binding,GO:0070063~RNA polymerase binding,GO:1990247~N6-methyladenosine-containing RNA binding,	IPR001374:Single-stranded nucleic acid binding R3H,IPR001650:Helicase, C-terminal,IPR002110:Ankyrin repeat,IPR007275:YTH domain,IPR007502:Helicase-associated domain,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR011709:Domain of unknown function DUF1605,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR020683:Ankyrin repeat-containing domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00393:R3H,SM00487:DEXDc,SM00490:HELICc,SM00847:SM00847,	3D-structure,ANK repeat,ATP-binding,Complete proteome,Helicase,Hydrolase,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-binding,	chain:Probable ATP-dependent RNA helicase YTHDC2,compositionally biased region:Gly-rich,compositionally biased region:Ser-rich,domain:Helicase ATP-binding,domain:Helicase C-terminal,domain:R3H,domain:YTH,helix,modified residue,nucleotide phosphate-binding region:ATP,repeat:ANK 1,repeat:ANK 2,sequence conflict,sequence variant,short sequence motif:DEAH box,strand,
ADNP	activity dependent neuroprotector homeobox(ADNP)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007614~short-term memory,GO:0009743~response to carbohydrate,GO:0010035~response to inorganic substance,GO:0010629~negative regulation of gene expression,GO:0010835~regulation of protein ADP-ribosylation,GO:0030828~positive regulation of cGMP biosynthetic process,GO:0031668~cellular response to extracellular stimulus,GO:0032091~negative regulation of protein binding,GO:0032147~activation of protein kinase activity,GO:0033484~nitric oxide homeostasis,GO:0043524~negative regulation of neuron apoptotic process,GO:0044849~estrous cycle,GO:0045773~positive regulation of axon extension,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050805~negative regulation of synaptic transmission,GO:0051965~positive regulation of synapse assembly,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0030424~axon,GO:0030425~dendrite,GO:0043025~neuronal cell body,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0005507~copper ion binding,GO:0005515~protein binding,GO:0042277~peptide binding,GO:0046872~metal ion binding,GO:0048487~beta-tubulin binding,	IPR001356:Homeodomain,IPR007087:Zinc finger, C2H2,IPR009057:Homeodomain-like,IPR015880:Zinc finger, C2H2-like,		615873~Helsmoortel-van der Aa syndrome,		SM00355:ZnF_C2H2,SM00389:HOX,	Acetylation,Autism spectrum disorder,Complete proteome,DNA-binding,Homeobox,Isopeptide bond,Mental retardation,Metal-binding,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Activity-dependent neuroprotector homeobox protein,DNA-binding region:Homeobox,modified residue,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2; atypical,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5; atypical,zinc finger region:C2H2-type 6; atypical,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8; atypical,zinc finger region:C2H2-type 9; atypical,
ASXL2	additional sex combs like 2, transcriptional regulator(ASXL2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0035360~positive regulation of peroxisome proliferator activated receptor signaling pathway,GO:0045600~positive regulation of fat cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005654~nucleoplasm,	GO:0003677~DNA binding,GO:0042975~peroxisome proliferator activated receptor binding,GO:0046872~metal ion binding,	IPR007759:DNA-directed RNA polymerase delta subunit,IPR024811:Polycomb protein ASX/ASX-like,IPR024817:ASX-like protein 2,IPR026905:Protein ASX-like, PHD domain,					Alternative splicing,Chromosomal rearrangement,Complete proteome,Metal-binding,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Putative Polycomb group protein ASXL2,compositionally biased region:Ala-rich,compositionally biased region:Gly-rich,compositionally biased region:Poly-Leu,compositionally biased region:Poly-Ser,compositionally biased region:Ser-rich,modified residue,sequence conflict,sequence variant,short sequence motif:LXXLL motif 1,short sequence motif:LXXLL motif 2,short sequence motif:Nuclear localization signal,site:Breakpoint for translocation to form MYST3-ASXL2 protein,splice variant,zinc finger region:PHD-type; atypical,
ASTE1	asteroid homolog 1 (Drosophila)(ASTE1)	Homo sapiens				GO:0006281~DNA repair,GO:0090305~nucleic acid phosphodiester bond hydrolysis,		GO:0004518~nuclease activity,GO:0005515~protein binding,	IPR006085:XPG N-terminal,IPR026832:Asteroid,					Alternative splicing,Complete proteome,Proteomics identification,Reference proteome,	chain:Protein asteroid homolog 1,sequence conflict,
BMPR2	bone morphogenetic protein receptor type 2(BMPR2)	Homo sapiens		h_alkPathway:ALK in cardiac myocytes,		GO:0001707~mesoderm formation,GO:0001893~maternal placenta development,GO:0001935~endothelial cell proliferation,GO:0001938~positive regulation of endothelial cell proliferation,GO:0001946~lymphangiogenesis,GO:0001974~blood vessel remodeling,GO:0002063~chondrocyte development,GO:0003085~negative regulation of systemic arterial blood pressure,GO:0003148~outflow tract septum morphogenesis,GO:0003151~outflow tract morphogenesis,GO:0003181~atrioventricular valve morphogenesis,GO:0003183~mitral valve morphogenesis,GO:0003186~tricuspid valve morphogenesis,GO:0003197~endocardial cushion development,GO:0003252~negative regulation of cell proliferation involved in heart valve morphogenesis,GO:0006366~transcription from RNA polymerase II promoter,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007420~brain development,GO:0009267~cellular response to starvation,GO:0009952~anterior/posterior pattern specification,GO:0010595~positive regulation of endothelial cell migration,GO:0010634~positive regulation of epithelial cell migration,GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation,GO:0014916~regulation of lung blood pressure,GO:0023014~signal transduction by protein phosphorylation,GO:0030166~proteoglycan biosynthetic process,GO:0030308~negative regulation of cell growth,GO:0030501~positive regulation of bone mineralization,GO:0030509~BMP signaling pathway,GO:0030513~positive regulation of BMP signaling pathway,GO:0032924~activin receptor signaling pathway,GO:0042127~regulation of cell proliferation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045778~positive regulation of ossification,GO:0045906~negative regulation of vasoconstriction,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048286~lung alveolus development,GO:0048738~cardiac muscle tissue development,GO:0048842~positive regulation of axon extension involved in axon guidance,GO:0060173~limb development,GO:0060350~endochondral bone morphogenesis,GO:0060412~ventricular septum morphogenesis,GO:0060413~atrial septum morphogenesis,GO:0060836~lymphatic endothelial cell differentiation,GO:0060840~artery development,GO:0060841~venous blood vessel development,GO:0061036~positive regulation of cartilage development,GO:0061298~retina vasculature development in camera-type eye,GO:0061626~pharyngeal arch artery morphogenesis,GO:0071773~cellular response to BMP stimulus,GO:0072577~endothelial cell apoptotic process,GO:1902731~negative regulation of chondrocyte proliferation,GO:2000279~negative regulation of DNA biosynthetic process,	GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005901~caveola,GO:0005911~cell-cell junction,GO:0009925~basal plasma membrane,GO:0009986~cell surface,GO:0014069~postsynaptic density,GO:0016324~apical plasma membrane,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0044214~spanning component of plasma membrane,	GO:0004702~receptor signaling protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016362~activin receptor activity, type II,GO:0019838~growth factor binding,GO:0036122~BMP binding,GO:0046872~metal ion binding,GO:0098821~BMP receptor activity,	IPR000333:Activin type II/Transforming growth factor-beta II receptor,IPR000472:TGF-beta receptor/activin receptor, type I/II,IPR000719:Protein kinase, catalytic domain,IPR011009:Protein kinase-like domain,IPR015770:Bone morphogenic protein type II receptor,IPR017441:Protein kinase, ATP binding site,	hsa04060:Cytokine-cytokine receptor interaction,hsa04350:TGF-beta signaling pathway,hsa04390:Hippo signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa05206:MicroRNAs in cancer,	178600~Pulmonary hypertension, familial primary, 1, with or without HHT,178600~Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated,265450~Pulmonary venoocclusive disease 1,			3D-structure,Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Disease mutation,Disulfide bond,Glycoprotein,Kinase,Magnesium,Manganese,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Serine/threonine-protein kinase,Signal,Transferase,Transmembrane,Transmembrane helix,	active site:Proton acceptor,binding site:ATP,chain:Bone morphogenetic protein receptor type- 2,compositionally biased region:Poly-Asn,compositionally biased region:Poly-Ser,compositionally biased region:Poly-Thr,disulfide bond,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
CTNND1	catenin delta 1(CTNND1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007155~cell adhesion,GO:0007420~brain development,GO:0016055~Wnt signaling pathway,GO:0016337~single organismal cell-cell adhesion,GO:0034332~adherens junction organization,GO:0090090~negative regulation of canonical Wnt signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005913~cell-cell adherens junction,GO:0005915~zonula adherens,GO:0030027~lamellipodium,GO:0030426~growth cone,GO:0030496~midbody,GO:0043197~dendritic spine,GO:0070062~extracellular exosome,	GO:0005102~receptor binding,GO:0005515~protein binding,GO:0019901~protein kinase binding,GO:0045296~cadherin binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000225:Armadillo,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,	hsa04015:Rap1 signaling pathway,hsa04520:Adherens junction,hsa04670:Leukocyte transendothelial migration,			SM00185:ARM,	3D-structure,Acetylation,Alternative initiation,Alternative splicing,Cell adhesion,Cell membrane,Coiled coil,Complete proteome,Cytoplasm,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Wnt signaling pathway,	chain:Catenin delta-1,modified residue,repeat:ARM 1,repeat:ARM 10,repeat:ARM 2,repeat:ARM 3,repeat:ARM 4,repeat:ARM 5,repeat:ARM 6,repeat:ARM 7,repeat:ARM 8,repeat:ARM 9,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,
CNTN6	contactin 6(CNTN6)	Homo sapiens				GO:0007155~cell adhesion,GO:0007219~Notch signaling pathway,GO:0007417~central nervous system development,GO:0030182~neuron differentiation,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0031225~anchored component of membrane,	GO:0005112~Notch binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,				SM00060:FN3,SM00408:IGc2,SM00409:IG,	Cell adhesion,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,GPI-anchor,Immunoglobulin domain,Lipoprotein,Membrane,Notch signaling pathway,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Contactin-6,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated serine,modified residue,propeptide:Removed in mature form,sequence variant,signal peptide,
COBLL1	cordon-bleu WH2 repeat protein like 1(COBLL1)	Homo sapiens				GO:0030041~actin filament polymerization,GO:0051639~actin filament network formation,GO:0098609~cell-cell adhesion,	GO:0005913~cell-cell adherens junction,GO:0070062~extracellular exosome,	GO:0003785~actin monomer binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR003124:WH2 domain,IPR019025:Cordon-bleu domain,					3D-structure,Alternative splicing,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:Cordon-bleu protein-like 1,domain:WH2,helix,modified residue,sequence conflict,short sequence motif:KKRRAP 1,short sequence motif:KKRRAP 2,splice variant,strand,turn,
CDKN2A	cyclin dependent kinase inhibitor 2A(CDKN2A)	Homo sapiens	1.RBphosphoE2F,26.cyclin-CDK_complexes,94.E2F_transcriptional_activity_cell_cycle,	h_arfPathway:Tumor Suppressor Arf Inhibits Ribosomal Biogenesis,h_cellcyclePathway:Cyclins and Cell Cycle Regulation,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,h_g1Pathway:Cell Cycle: G1/S Check Point ,		GO:0000082~G1/S transition of mitotic cell cycle,GO:0000209~protein polyubiquitination,GO:0000422~mitophagy,GO:0001953~negative regulation of cell-matrix adhesion,GO:0006351~transcription, DNA-templated,GO:0006364~rRNA processing,GO:0006469~negative regulation of protein kinase activity,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0007050~cell cycle arrest,GO:0007265~Ras protein signal transduction,GO:0008285~negative regulation of cell proliferation,GO:0008637~apoptotic mitochondrial changes,GO:0010389~regulation of G2/M transition of mitotic cell cycle,GO:0016925~protein sumoylation,GO:0030308~negative regulation of cell growth,GO:0030889~negative regulation of B cell proliferation,GO:0031647~regulation of protein stability,GO:0031648~protein destabilization,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0033088~negative regulation of immature T cell proliferation in thymus,GO:0033235~positive regulation of protein sumoylation,GO:0034393~positive regulation of smooth muscle cell apoptotic process,GO:0035986~senescence-associated heterochromatin focus assembly,GO:0042326~negative regulation of phosphorylation,GO:0043065~positive regulation of apoptotic process,GO:0043517~positive regulation of DNA damage response, signal transduction by p53 class mediator,GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046825~regulation of protein export from nucleus,GO:0048103~somatic stem cell division,GO:0050821~protein stabilization,GO:0051444~negative regulation of ubiquitin-protein transferase activity,GO:0051882~mitochondrial depolarization,GO:0070534~protein K63-linked ubiquitination,GO:0071158~positive regulation of cell cycle arrest,GO:0090398~cellular senescence,GO:0090399~replicative senescence,GO:1900182~positive regulation of protein localization to nucleus,GO:1901798~positive regulation of signal transduction by p53 class mediator,GO:1902510~regulation of apoptotic DNA fragmentation,GO:1903051~negative regulation of proteolysis involved in cellular protein catabolic process,GO:1903214~regulation of protein targeting to mitochondrion,GO:2000059~negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:2000111~positive regulation of macrophage apoptotic process,GO:2000774~positive regulation of cellular senescence,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0035985~senescence-associated heterochromatin focus,GO:0043234~protein complex,	GO:0002039~p53 binding,GO:0003677~DNA binding,GO:0004861~cyclin-dependent protein serine/threonine kinase inhibitor activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0016301~kinase activity,GO:0019789~SUMO transferase activity,GO:0019901~protein kinase binding,GO:0044822~poly(A) RNA binding,GO:0051059~NF-kappaB binding,GO:0055105~ubiquitin-protein transferase inhibitor activity,GO:0097371~MDM2/MDM4 family protein binding,	IPR010868:Cyclin-dependent kinase inhibitor 2A,IPR020683:Ankyrin repeat-containing domain,	hsa04110:Cell cycle,hsa04115:p53 signaling pathway,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05206:MicroRNAs in cancer,hsa05212:Pancreatic cancer,hsa05214:Glioma,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05223:Non-small cell lung cancer,	155601~Melanoma, cutaneous malignant, 2,155755~Melanoma and neural system tumor syndrome,606719~Pancreatic cancer/melanoma syndrome,Orolaryngeal cancer, multiple,~Orolaryngeal cancer, multiple,,			3D-structure,Acetylation,Alternative splicing,ANK repeat,Apoptosis,Cell cycle,Complete proteome,Cyclin,Cytoplasm,Disease mutation,DNA-binding,Kinase,Li-Fraumeni syndrome,Mitochondrion,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,rRNA processing,Transcription,Transcription regulation,Transferase,Tumor suppressor,Ubl conjugation,Ubl conjugation pathway,	chain:Cyclin-dependent kinase inhibitor 2A, isoform 4,chain:Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3,helix,modified residue,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,sequence conflict,sequence variant,splice variant,strand,turn,
ESRP1	epithelial splicing regulatory protein 1(ESRP1)	Homo sapiens				GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0043484~regulation of RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003729~mRNA binding,GO:0005515~protein binding,	IPR000504:RNA recognition motif domain,IPR012337:Ribonuclease H-like domain,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,	3D-structure,Alternative splicing,Complete proteome,Methylation,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-binding,	chain:Epithelial splicing regulatory protein 1,domain:RRM 1,domain:RRM 2,domain:RRM 3,helix,sequence conflict,sequence variant,splice variant,strand,turn,
EIF2AK1	eukaryotic translation initiation factor 2 alpha kinase 1(EIF2AK1)	Homo sapiens		h_eif2Pathway:Regulation of eIF2,		GO:0002526~acute inflammatory response,GO:0006909~phagocytosis,GO:0006950~response to stress,GO:0008285~negative regulation of cell proliferation,GO:0009605~response to external stimulus,GO:0010998~regulation of translational initiation by eIF2 alpha phosphorylation,GO:0010999~regulation of eIF2 alpha phosphorylation by heme,GO:0030225~macrophage differentiation,GO:0045993~negative regulation of translational initiation by iron,GO:0046501~protoporphyrinogen IX metabolic process,GO:0046777~protein autophosphorylation,GO:0046986~negative regulation of hemoglobin biosynthetic process,GO:0055072~iron ion homeostasis,	GO:0005737~cytoplasm,	GO:0003743~translation initiation factor activity,GO:0004694~eukaryotic translation initiation factor 2alpha kinase activity,GO:0005524~ATP binding,GO:0020037~heme binding,GO:0042803~protein homodimerization activity,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	hsa04141:Protein processing in endoplasmic reticulum,hsa05160:Hepatitis C,hsa05162:Measles,hsa05164:Influenza A,hsa05168:Herpes simplex infection,			SM00220:S_TKc,	Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Cytoplasm,Disulfide bond,Initiation factor,Kinase,Nucleotide-binding,Phosphoprotein,Polymorphism,Protein biosynthesis,Protein synthesis inhibitor,Proteomics identification,Reference proteome,Repeat,Serine/threonine-protein kinase,Signal,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Eukaryotic translation initiation factor 2-alpha kinase 1,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,repeat:HRM 1,repeat:HRM 2,sequence conflict,sequence variant,splice variant,
FAM111B	family with sequence similarity 111 member B(FAM111B)	Homo sapiens						GO:0005515~protein binding,	IPR009003:Trypsin-like cysteine/serine peptidase domain,		615704~Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis,			Acetylation,Alternative splicing,Complete proteome,Disease mutation,Polymorphism,Proteomics identification,Reference proteome,	chain:Protein FAM111B,sequence conflict,sequence variant,splice variant,
GRIK2	glutamate ionotropic receptor kainate type subunit 2(GRIK2)	Homo sapiens				GO:0001662~behavioral fear response,GO:0006810~transport,GO:0006874~cellular calcium ion homeostasis,GO:0006886~intracellular protein transport,GO:0007215~glutamate receptor signaling pathway,GO:0007268~chemical synaptic transmission,GO:0019228~neuronal action potential,GO:0034220~ion transmembrane transport,GO:0035235~ionotropic glutamate receptor signaling pathway,GO:0035249~synaptic transmission, glutamatergic,GO:0043113~receptor clustering,GO:0043524~negative regulation of neuron apoptotic process,GO:0043525~positive regulation of neuron apoptotic process,GO:0046328~regulation of JNK cascade,GO:0048169~regulation of long-term neuronal synaptic plasticity,GO:0048172~regulation of short-term neuronal synaptic plasticity,GO:0050804~modulation of synaptic transmission,GO:0050806~positive regulation of synaptic transmission,GO:0051402~neuron apoptotic process,GO:0051967~negative regulation of synaptic transmission, glutamatergic,GO:0060079~excitatory postsynaptic potential,GO:0060080~inhibitory postsynaptic potential,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0014069~postsynaptic density,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0032839~dendrite cytoplasm,GO:0032983~kainate selective glutamate receptor complex,GO:0042734~presynaptic membrane,GO:0043195~terminal bouton,GO:0043204~perikaryon,GO:0045211~postsynaptic membrane,	GO:0004970~ionotropic glutamate receptor activity,GO:0005234~extracellular-glutamate-gated ion channel activity,GO:0015276~ligand-gated ion channel activity,GO:0015277~kainate selective glutamate receptor activity,GO:0030165~PDZ domain binding,GO:0031624~ubiquitin conjugating enzyme binding,GO:0031625~ubiquitin protein ligase binding,GO:0042803~protein homodimerization activity,	IPR001320:Ionotropic glutamate receptor,IPR001508:NMDA receptor,IPR001828:Extracellular ligand-binding receptor,IPR019594:Glutamate receptor, L-glutamate/glycine-binding,	hsa04080:Neuroactive ligand-receptor interaction,hsa04724:Glutamatergic synapse,	611092~Mental retardation, autosomal recessive, 6,		SM00079:PBPe,SM00918:SM00918,	3D-structure,Alternative splicing,Cell junction,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Ion channel,Ion transport,Isopeptide bond,Ligand-gated ion channel,Membrane,Mental retardation,Phosphoprotein,Polymorphism,Postsynaptic cell membrane,Proteomics identification,Receptor,Reference proteome,RNA editing,Signal,Synapse,Transmembrane,Transmembrane helix,Transport,Ubl conjugation,	binding site:Glutamate,chain:Glutamate receptor, ionotropic kainate 2,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO-1),glycosylation site:N-linked (GlcNAc...),region of interest:Glutamate binding,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GON4L	gon-4 like(GON4L)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0030183~B cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003714~transcription corepressor activity,	IPR003822:Paired amphipathic helix,IPR009057:Homeodomain-like,IPR017877:Myb-like domain,					Alternative splicing,Complete proteome,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,	chain:GON-4-like protein,chain:YY1-associated protein 1,compositionally biased region:Asp-rich,compositionally biased region:Glu-rich,compositionally biased region:Poly-Lys,compositionally biased region:Poly-Pro,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:Myb-like,modified residue,repeat:PAH 1,repeat:PAH 2,sequence conflict,sequence variant,splice variant,
HDAC2	histone deacetylase 2(HDAC2)	Homo sapiens		h_carm-erPathway:CARM1 and Regulation of the Estrogen Receptor,h_etsPathway:METS affect on Macrophage Differentiation,h_mef2dPathway:Role of MEF2D in T-cell Apoptosis,h_prc2Pathway:The PRC2 Complex Sets Long-term Gene Silencing Through Modification of Histone Tails,	Chromatin structure and dynamics / Secondary metabolites biosynthesis, transport, and catabolism,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001975~response to amphetamine,GO:0003300~cardiac muscle hypertrophy,GO:0006338~chromatin remodeling,GO:0006344~maintenance of chromatin silencing,GO:0006351~transcription, DNA-templated,GO:0007596~blood coagulation,GO:0008284~positive regulation of cell proliferation,GO:0009913~epidermal cell differentiation,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0010870~positive regulation of receptor biosynthetic process,GO:0010977~negative regulation of neuron projection development,GO:0016358~dendrite development,GO:0016575~histone deacetylation,GO:0031000~response to caffeine,GO:0032496~response to lipopolysaccharide,GO:0032732~positive regulation of interleukin-1 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0032922~circadian regulation of gene expression,GO:0032967~positive regulation of collagen biosynthetic process,GO:0034605~cellular response to heat,GO:0035094~response to nicotine,GO:0042220~response to cocaine,GO:0042475~odontogenesis of dentin-containing tooth,GO:0042493~response to drug,GO:0042517~positive regulation of tyrosine phosphorylation of Stat3 protein,GO:0042733~embryonic digit morphogenesis,GO:0043044~ATP-dependent chromatin remodeling,GO:0043066~negative regulation of apoptotic process,GO:0043392~negative regulation of DNA binding,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045347~negative regulation of MHC class II biosynthetic process,GO:0045862~positive regulation of proteolysis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048149~behavioral response to ethanol,GO:0048714~positive regulation of oligodendrocyte differentiation,GO:0055093~response to hyperoxia,GO:0060789~hair follicle placode formation,GO:0061000~negative regulation of dendritic spine development,GO:0061029~eyelid development in camera-type eye,GO:0061198~fungiform papilla formation,GO:0070301~cellular response to hydrogen peroxide,GO:0070932~histone H3 deacetylation,GO:0070933~histone H4 deacetylation,GO:0071300~cellular response to retinoic acid,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:1901796~regulation of signal transduction by p53 class mediator,GO:1903351~cellular response to dopamine,GO:2000757~negative regulation of peptidyl-lysine acetylation,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016021~integral component of membrane,GO:0016580~Sin3 complex,GO:0016581~NuRD complex,GO:0035098~ESC/E(Z) complex,GO:0043234~protein complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0001103~RNA polymerase II repressing transcription factor binding,GO:0003682~chromatin binding,GO:0004407~histone deacetylase activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019213~deacetylase activity,GO:0019899~enzyme binding,GO:0031072~heat shock protein binding,GO:0031492~nucleosomal DNA binding,GO:0032041~NAD-dependent histone deacetylase activity (H3-K14 specific),GO:0033558~protein deacetylase activity,GO:0043565~sequence-specific DNA binding,GO:0044822~poly(A) RNA binding,GO:0051059~NF-kappaB binding,	IPR000286:Histone deacetylase superfamily,IPR003084:Histone deacetylase,IPR023801:Histone deacetylase domain,	hsa04110:Cell cycle,hsa04330:Notch signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa05016:Huntington's disease,hsa05034:Alcoholism,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05203:Viral carcinogenesis,hsa05220:Chronic myeloid leukemia,		PIRSF037913:histone deacetylase class I, eukaryotic type,		3D-structure,Acetylation,Alternative splicing,Biological rhythms,Chromatin regulator,Complete proteome,Cytoplasm,Hydrolase,Isopeptide bond,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,S-nitrosylation,Transcription,Transcription regulation,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Histone deacetylase 2,compositionally biased region:Poly-Gly,modified residue,region of interest:Histone deacetylase,sequence conflict,sequence variant,splice variant,
KDM5C	lysine demethylase 5C(KDM5C)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0034720~histone H3-K4 demethylation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048511~rhythmic process,GO:0055114~oxidation-reduction process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0016706~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,GO:0032452~histone demethylase activity,GO:0032453~histone demethylase activity (H3-K4 specific),	IPR001606:ARID/BRIGHT DNA-binding domain,IPR001965:Zinc finger, PHD-type,IPR003347:JmjC domain,IPR003349:Transcription factor jumonji, JmjN,IPR004198:Zinc finger, C5HC2-type,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013637:Lysine-specific demethylase-like domain,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,		300534~Mental retardation, X-linked, syndromic, Claes-Jensen type,		SM00249:PHD,SM00501:BRIGHT,SM00545:JmjN,SM00558:JmjC,	3D-structure,Alternative splicing,Biological rhythms,Chromatin regulator,Complete proteome,Dioxygenase,Disease mutation,Iron,Mental retardation,Metal-binding,Nucleus,Oxidoreductase,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Lysine-specific demethylase 5C,domain:ARID,domain:JmjC,domain:JmjN,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,turn,zinc finger region:PHD-type 1,zinc finger region:PHD-type 2,
KDM6A	lysine demethylase 6A(KDM6A)	Homo sapiens				GO:0001701~in utero embryonic development,GO:0001843~neural tube closure,GO:0003007~heart morphogenesis,GO:0003016~respiratory system process,GO:0010628~positive regulation of gene expression,GO:0032525~somite rostral/caudal axis specification,GO:0035264~multicellular organism growth,GO:0048333~mesodermal cell differentiation,GO:0048570~notochord morphogenesis,GO:0051568~histone H3-K4 methylation,GO:0055114~oxidation-reduction process,GO:0060070~canonical Wnt signaling pathway,GO:0071557~histone H3-K27 demethylation,GO:0072358~cardiovascular system development,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0035097~histone methyltransferase complex,GO:0044666~MLL3/4 complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0031490~chromatin DNA binding,GO:0032452~histone demethylase activity,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0051213~dioxygenase activity,GO:0071558~histone demethylase activity (H3-K27 specific),	IPR001440:Tetratricopeptide TPR-1,IPR003347:JmjC domain,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,	hsa05202:Transcriptional misregulation in cancer,	300867~Kabuki syndrome 2,		SM00028:TPR,SM00558:JmjC,	3D-structure,Chromatin regulator,Complete proteome,Dioxygenase,Iron,Mental retardation,Metal-binding,Methylation,Nucleus,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,TPR repeat,Zinc,	chain:Lysine-specific demethylase 6A,compositionally biased region:Poly-Ala,domain:JmjC,modified residue,mutagenesis site,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,repeat:TPR 5,repeat:TPR 6,repeat:TPR 7,repeat:TPR 8,sequence conflict,sequence variant,
KMT2D	lysine methyltransferase 2D(KMT2D)	Homo sapiens			General function prediction only,	GO:0001555~oocyte growth,GO:0006342~chromatin silencing,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0008284~positive regulation of cell proliferation,GO:0033148~positive regulation of intracellular estrogen receptor signaling pathway,GO:0043627~response to estrogen,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048477~oogenesis,GO:0051568~histone H3-K4 methylation,GO:1904837~beta-catenin-TCF complex assembly,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0035097~histone methyltransferase complex,GO:0044666~MLL3/4 complex,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008168~methyltransferase activity,GO:0008270~zinc ion binding,GO:0018024~histone-lysine N-methyltransferase activity,GO:0042800~histone methyltransferase activity (H3-K4 specific),GO:0044212~transcription regulatory region DNA binding,	IPR001214:SET domain,IPR001841:Zinc finger, RING-type,IPR001965:Zinc finger, PHD-type,IPR003616:Post-SET domain,IPR003888:FY-rich, N-terminal,IPR003889:FY-rich, C-terminal,IPR009071:High mobility group (HMG) box domain,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019787:Zinc finger, PHD-finger,	hsa00310:Lysine degradation,	147920~Kabuki syndrome 1,		SM00184:RING,SM00249:PHD,SM00317:SET,SM00398:HMG,SM00508:PostSET,SM00541:FYRN,SM00542:FYRC,	3D-structure,Acetylation,Alternative splicing,Chromatin regulator,Coiled coil,Complete proteome,Disease mutation,Isopeptide bond,Mental retardation,Metal-binding,Methylation,Methyltransferase,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,S-adenosyl-L-methionine,Transcription,Transcription regulation,Transferase,Ubl conjugation,Zinc,Zinc-finger,	binding site:S-adenosyl-L-methionine,chain:Histone-lysine N-methyltransferase MLL2,compositionally biased region:Arg-rich,compositionally biased region:Cys-rich,compositionally biased region:Gln-rich,compositionally biased region:Pro-rich,domain:Post-SET,domain:SET,metal ion-binding site:Zinc,modified residue,region of interest:15 X 5 AA repeats of S/P-P-P-E/P-E/A,region of interest:S-adenosyl-L-methionine binding,repeat:1,repeat:10,repeat:11,repeat:12,repeat:13,repeat:14,repeat:15,repeat:2,repeat:3,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9,sequence variant,short sequence motif:LXXLL motif 1,short sequence motif:LXXLL motif 2,short sequence motif:LXXLL motif 3,short sequence motif:LXXLL motif 4,short sequence motif:LXXLL motif 5,short sequence motif:LXXLL motif 6,splice variant,zinc finger region:PHD-type 1,zinc finger region:PHD-type 2,zinc finger region:PHD-type 3,zinc finger region:PHD-type 4,zinc finger region:PHD-type 5,zinc finger region:RING-type,
HLA-A	major histocompatibility complex, class I, A(HLA-A)	Homo sapiens	70.Signal_peptides_(MHC)_class_I_molecules,	h_ctlPathway:CTL mediated immune response against target cells ,h_mhcPathway:Antigen Processing and Presentation,h_nkcellsPathway:Ras-Independent pathway in NK cell-mediated cytotoxicity,		GO:0001916~positive regulation of T cell mediated cytotoxicity,GO:0002474~antigen processing and presentation of peptide antigen via MHC class I,GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,GO:0002480~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,GO:0002486~antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent,GO:0002726~positive regulation of T cell cytokine production,GO:0006955~immune response,GO:0016032~viral process,GO:0016045~detection of bacterium,GO:0019731~antibacterial humoral response,GO:0019882~antigen processing and presentation,GO:0019885~antigen processing and presentation of endogenous peptide antigen via MHC class I,GO:0032729~positive regulation of interferon-gamma production,GO:0042270~protection from natural killer cell mediated cytotoxicity,GO:0050690~regulation of defense response to virus by virus,GO:0050776~regulation of immune response,GO:0050830~defense response to Gram-positive bacterium,GO:0060333~interferon-gamma-mediated signaling pathway,GO:0060337~type I interferon signaling pathway,GO:2000566~positive regulation of CD8-positive, alpha-beta T cell proliferation,GO:2000568~positive regulation of memory T cell activation,GO:2001187~positive regulation of CD8-positive, alpha-beta T cell activation,	GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005797~Golgi medial cisterna,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0012507~ER to Golgi transport vesicle membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030670~phagocytic vesicle membrane,GO:0031901~early endosome membrane,GO:0042612~MHC class I protein complex,GO:0042613~MHC class II protein complex,GO:0070062~extracellular exosome,GO:0070971~endoplasmic reticulum exit site,GO:0071556~integral component of lumenal side of endoplasmic reticulum membrane,	GO:0005102~receptor binding,GO:0005515~protein binding,GO:0030881~beta-2-microglobulin binding,GO:0042605~peptide antigen binding,GO:0042608~T cell receptor binding,GO:0044822~poly(A) RNA binding,GO:0046977~TAP binding,	IPR000353:MHC class II, beta chain, N-terminal,IPR001039:MHC class I, alpha chain, alpha1/alpha2,IPR003006:Immunoglobulin/major histocompatibility complex, conserved site,IPR003597:Immunoglobulin C1-set,IPR007110:Immunoglobulin-like domain,IPR010579:MHC class I, alpha chain, C-terminal,IPR011161:MHC class I-like antigen recognition,IPR011162:MHC classes I/II-like antigen recognition protein,IPR013783:Immunoglobulin-like fold,IPR014745:MHC class II, alpha/beta chain, N-terminal,	hsa04144:Endocytosis,hsa04145:Phagosome,hsa04514:Cell adhesion molecules (CAMs),hsa04612:Antigen processing and presentation,hsa04940:Type I diabetes mellitus,hsa05166:HTLV-I infection,hsa05168:Herpes simplex infection,hsa05169:Epstein-Barr virus infection,hsa05203:Viral carcinogenesis,hsa05320:Autoimmune thyroid disease,hsa05330:Allograft rejection,hsa05332:Graft-versus-host disease,hsa05416:Viral myocarditis,	608579~Hypersensitivity syndrome, carbamazepine-induced, susceptibility to,		SM00407:IGc1,SM00921:SM00921,	3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Host-virus interaction,Immunity,Immunoglobulin domain,Membrane,MHC I,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Sulfation,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:HLA class I histocompatibility antigen, A-1 alpha chain,chain:HLA class I histocompatibility antigen, A-11 alpha chain,chain:HLA class I histocompatibility antigen, A-2 alpha chain,chain:HLA class I histocompatibility antigen, A-23 alpha chain,chain:HLA class I histocompatibility antigen, A-24 alpha chain,chain:HLA class I histocompatibility antigen, A-25 alpha chain,chain:HLA class I histocompatibility antigen, A-26 alpha chain,chain:HLA class I histocompatibility antigen, A-29 alpha chain,chain:HLA class I histocompatibility antigen, A-3 alpha chain,chain:HLA class I histocompatibility antigen, A-31 alpha chain,chain:HLA class I histocompatibility antigen, A-32 alpha chain,chain:HLA class I histocompatibility antigen, A-34 alpha chain,chain:HLA class I histocompatibility antigen, A-36 alpha chain,chain:HLA class I histocompatibility antigen, A-43 alpha chain,chain:HLA class I histocompatibility antigen, A-66 alpha chain,chain:HLA class I histocompatibility antigen, A-68 alpha chain,chain:HLA class I histocompatibility antigen, A-69 alpha chain,chain:HLA class I histocompatibility antigen, A-80 alpha chain,chain:MHC class I antigen,disulfide bond,domain:Ig-like C1-type,glycosylation site:N-linked (GlcNAc...),helix,modified residue,region of interest:Alpha-1,region of interest:Alpha-2,region of interest:Alpha-3,region of interest:Connecting peptide,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
MED23	mediator complex subunit 23(MED23)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,	GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,	GO:0003713~transcription coactivator activity,GO:0005515~protein binding,	IPR021629:Mediator complex, subunit Med23,		614249~Mental retardation, autosomal recessive 18,			Activator,Alternative splicing,Complete proteome,Direct protein sequencing,Disease mutation,Mental retardation,Nucleus,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Mediator of RNA polymerase II transcription subunit 23,modified residue,sequence conflict,splice variant,
MBD6	methyl-CpG binding domain protein 6(MBD6)	Homo sapiens					GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0010369~chromocenter,	GO:0003677~DNA binding,GO:0003682~chromatin binding,	IPR001739:Methyl-CpG DNA binding,IPR016177:DNA-binding, integrase-type,				SM00391:MBD,	Chromosome,Complete proteome,Nucleus,Proteomics identification,Reference proteome,	chain:Methyl-CpG-binding domain protein 6,compositionally biased region:Pro-rich,domain:MBD,sequence conflict,
MAP2K4	mitogen-activated protein kinase kinase 4(MAP2K4)	Homo sapiens	100.MAPK_signaling_cascades,77.IkBa_Kinase_JNK_MEKK1,	h_at1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,h_ceramidePathway:Ceramide Signaling Pathway,h_egfPathway:EGF Signaling Pathway,h_fasPathway:FAS signaling pathway ( CD95 ),h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,h_gleevecPathway:Inhibition of Cellular Proliferation by Gleevec,h_keratinocytePathway:Keratinocyte Differentiation,h_mapkPathway:MAPKinase Signaling Pathway,h_p38mapkPathway:p38 MAPK Signaling Pathway ,h_pdgfPathway:PDGF Signaling Pathway,h_pyk2Pathway:Links between Pyk2 and Map Kinases,h_stressPathway:TNF/Stress Related Signaling,h_tcrPathway:T Cell Receptor Signaling Pathway,h_tnfr1Pathway:TNFR1 Signaling Pathway,h_tollPathway:Toll-Like Receptor Pathway,		GO:0006915~apoptotic process,GO:0007165~signal transduction,GO:0007254~JNK cascade,GO:0007257~activation of JUN kinase activity,GO:0009611~response to wounding,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0034393~positive regulation of smooth muscle cell apoptotic process,GO:0035897~proteolysis in other organism,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0043525~positive regulation of neuron apoptotic process,GO:0045740~positive regulation of DNA replication,GO:0051770~positive regulation of nitric-oxide synthase biosynthetic process,GO:0061049~cell growth involved in cardiac muscle cell development,GO:0071260~cellular response to mechanical stimulus,GO:0072709~cellular response to sorbitol,GO:2000672~negative regulation of motor neuron apoptotic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0030424~axon,GO:0032839~dendrite cytoplasm,GO:0043204~perikaryon,	GO:0004672~protein kinase activity,GO:0004702~receptor signaling protein serine/threonine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008545~JUN kinase kinase activity,GO:0031435~mitogen-activated protein kinase kinase kinase binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04620:Toll-like receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04668:TNF signaling pathway,hsa04912:GnRH signaling pathway,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05142:Chagas disease (American trypanosomiasis),hsa05161:Hepatitis B,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05169:Epstein-Barr virus infection,			SM00220:S_TKc,	3D-structure,Acetylation,Alternative splicing,Apoptosis,ATP-binding,Complete proteome,Cytoplasm,Kinase,Methylation,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Stress response,Transferase,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Dual specificity mitogen-activated protein kinase kinase 4,compositionally biased region:Gly/Ser-rich,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,site:Cleavage; by anthrax lethal factor,
MAP3K1	mitogen-activated protein kinase kinase kinase 1(MAP3K1)	Homo sapiens	100.MAPK_signaling_cascades,102.Cholesterol_Stress_Response,158.14-3-3_signal_transduction,159.14-3-3_Apoptosis,68.Mitogen_signaling_in_growth_control,77.IkBa_Kinase_JNK_MEKK1,	h_41BBPathway:The 4-1BB-dependent immune response,h_at1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,h_bcrPathway:BCR Signaling Pathway,h_cd40Pathway:CD40L Signaling Pathway,h_ceramidePathway:Ceramide Signaling Pathway,h_egfPathway:EGF Signaling Pathway,h_egfr_smrtePathway:Map Kinase Inactivation of SMRT Corepressor,h_fasPathway:FAS signaling pathway ( CD95 ),h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,h_fmlpPathway:fMLP induced chemokine gene expression in HMC-1 cells,h_gleevecPathway:Inhibition of Cellular Proliferation by Gleevec,h_hcmvPathway:Human Cytomegalovirus and Map Kinase Pathways,h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_il1rPathway:Signal transduction through IL1R,h_keratinocytePathway:Keratinocyte Differentiation,h_malPathway:Role of MAL in Rho-Mediated Activation of SRF,h_mapkPathway:MAPKinase Signaling Pathway,h_nfkbPathway:NF-kB Signaling Pathway,h_p38mapkPathway:p38 MAPK Signaling Pathway ,h_pdgfPathway:PDGF Signaling Pathway,h_pyk2Pathway:Links between Pyk2 and Map Kinases,h_rac1Pathway:Rac 1 cell motility signaling pathway,h_stressPathway:TNF/Stress Related Signaling,h_tcrPathway:T Cell Receptor Signaling Pathway,h_tnfr1Pathway:TNFR1 Signaling Pathway,h_tnfr2Pathway:TNFR2 Signaling Pathway,h_tollPathway:Toll-Like Receptor Pathway,h_vipPathway:Neuropeptides VIP and PACAP inhibit the apoptosis of activated T cells,	General function prediction only,	GO:0000165~MAPK cascade,GO:0000186~activation of MAPKK activity,GO:0002755~MyD88-dependent toll-like receptor signaling pathway,GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0071260~cellular response to mechanical stimulus,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004702~receptor signaling protein serine/threonine kinase activity,GO:0004709~MAP kinase kinase kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0019901~protein kinase binding,	IPR000719:Protein kinase, catalytic domain,IPR001841:Zinc finger, RING-type,IPR007527:Zinc finger, SWIM-type,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR016024:Armadillo-type fold,IPR017441:Protein kinase, ATP binding site,	hsa04010:MAPK signaling pathway,hsa04120:Ubiquitin mediated proteolysis,hsa04622:RIG-I-like receptor signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04912:GnRH signaling pathway,hsa05161:Hepatitis B,hsa05166:HTLV-I infection,	613762~46XY sex reversal 6,		SM00220:S_TKc,	Acetylation,ATP-binding,Complete proteome,Kinase,Magnesium,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,Serine/threonine-protein kinase,Transferase,Zinc,Zinc-finger,	active site:Proton acceptor,binding site:ATP,chain:Mitogen-activated protein kinase kinase kinase 1,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Ile,compositionally biased region:Poly-Ser,compositionally biased region:Poly-Thr,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,zinc finger region:RING-type,zinc finger region:SWIM-type,
NF1	neurofibromin 1(NF1)	Homo sapiens		h_hSWI-SNFpathway:Chromatin Remodeling by hSWI/SNF ATP-dependent Complexes,		GO:0000165~MAPK cascade,GO:0001649~osteoblast differentiation,GO:0001656~metanephros development,GO:0001666~response to hypoxia,GO:0001889~liver development,GO:0001937~negative regulation of endothelial cell proliferation,GO:0001938~positive regulation of endothelial cell proliferation,GO:0001952~regulation of cell-matrix adhesion,GO:0001953~negative regulation of cell-matrix adhesion,GO:0006469~negative regulation of protein kinase activity,GO:0007154~cell communication,GO:0007165~signal transduction,GO:0007265~Ras protein signal transduction,GO:0007406~negative regulation of neuroblast proliferation,GO:0007420~brain development,GO:0007422~peripheral nervous system development,GO:0007507~heart development,GO:0007519~skeletal muscle tissue development,GO:0008542~visual learning,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0010468~regulation of gene expression,GO:0014044~Schwann cell development,GO:0014065~phosphatidylinositol 3-kinase signaling,GO:0016525~negative regulation of angiogenesis,GO:0021510~spinal cord development,GO:0021764~amygdala development,GO:0021897~forebrain astrocyte development,GO:0021915~neural tube development,GO:0021987~cerebral cortex development,GO:0022011~myelination in peripheral nervous system,GO:0030036~actin cytoskeleton organization,GO:0030198~extracellular matrix organization,GO:0030199~collagen fibril organization,GO:0030325~adrenal gland development,GO:0030336~negative regulation of cell migration,GO:0032228~regulation of synaptic transmission, GABAergic,GO:0034605~cellular response to heat,GO:0035021~negative regulation of Rac protein signal transduction,GO:0042060~wound healing,GO:0042992~negative regulation of transcription factor import into nucleus,GO:0043065~positive regulation of apoptotic process,GO:0043087~regulation of GTPase activity,GO:0043407~negative regulation of MAP kinase activity,GO:0043409~negative regulation of MAPK cascade,GO:0043473~pigmentation,GO:0043525~positive regulation of neuron apoptotic process,GO:0043535~regulation of blood vessel endothelial cell migration,GO:0043547~positive regulation of GTPase activity,GO:0045124~regulation of bone resorption,GO:0045671~negative regulation of osteoclast differentiation,GO:0045685~regulation of glial cell differentiation,GO:0045762~positive regulation of adenylate cyclase activity,GO:0045765~regulation of angiogenesis,GO:0046580~negative regulation of Ras protein signal transduction,GO:0046929~negative regulation of neurotransmitter secretion,GO:0048147~negative regulation of fibroblast proliferation,GO:0048169~regulation of long-term neuronal synaptic plasticity,GO:0048485~sympathetic nervous system development,GO:0048593~camera-type eye morphogenesis,GO:0048712~negative regulation of astrocyte differentiation,GO:0048715~negative regulation of oligodendrocyte differentiation,GO:0048745~smooth muscle tissue development,GO:0048844~artery morphogenesis,GO:0048853~forebrain morphogenesis,GO:0050890~cognition,GO:0061534~gamma-aminobutyric acid secretion, neurotransmission,GO:0061535~glutamate secretion, neurotransmission,GO:0098597~observational learning,GO:1900271~regulation of long-term synaptic potentiation,GO:1902043~positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:2001241~positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0031235~intrinsic component of the cytoplasmic side of the plasma membrane,GO:0098793~presynapse,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0008429~phosphatidylethanolamine binding,GO:0031210~phosphatidylcholine binding,	IPR001251:CRAL-TRIO domain,IPR001936:Ras GTPase-activating protein,IPR008936:Rho GTPase activation protein,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR023152:Ras GTPase-activating protein, conserved site,	hsa04010:MAPK signaling pathway,hsa04014:Ras signaling pathway,	162200~Neurofibromatosis, type 1,162210~Neurofibromatosis, familial spinal,193520~Watson syndrome,601321~Neurofibromatosis-Noonan syndrome,607785~Leukemia, juvenile myelomonocytic,		SM00323:RasGAP,SM00516:SEC14,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Disease mutation,GTPase activation,Lipid-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA editing,Tumor suppressor,	chain:Neurofibromin,chain:Neurofibromin truncated,compositionally biased region:Poly-Ser,domain:CRAL-TRIO,domain:Ras-GAP,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
NXF1	nuclear RNA export factor 1(NXF1)	Homo sapiens				GO:0006405~RNA export from nucleus,GO:0006406~mRNA export from nucleus,GO:0016032~viral process,GO:0016973~poly(A)+ mRNA export from nucleus,GO:0051028~mRNA transport,	GO:0000346~transcription export complex,GO:0005634~nucleus,GO:0005643~nuclear pore,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016607~nuclear speck,GO:0042405~nuclear inclusion body,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0003727~single-stranded RNA binding,GO:0003729~mRNA binding,GO:0005487~nucleocytoplasmic transporter activity,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR001611:Leucine-rich repeat,IPR002075:Nuclear transport factor 2,IPR005637:TAP C-terminal (TAP-C) domain,IPR009060:UBA-like,IPR012677:Nucleotide-binding, alpha-beta plait,IPR015245:Nuclear RNA export factor Tap, RNA-binding domain,IPR018222:Nuclear transport factor 2, Eukaryote,	hsa03008:Ribosome biogenesis in eukaryotes,hsa03013:RNA transport,hsa03015:mRNA surveillance pathway,hsa05164:Influenza A,hsa05168:Herpes simplex infection,			SM00804:TAP_C,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Host-virus interaction,Leucine-rich repeat,Methylation,mRNA transport,Nitration,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,Transport,	chain:Nuclear RNA export factor 1,compositionally biased region:Pro-rich,domain:NTF2,domain:RRM,domain:TAP-C,helix,modified residue,mutagenesis site,region of interest:Interaction with THOC4,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,sequence conflict,short sequence motif:Nuclear export signal,short sequence motif:Nuclear localization signal,strand,turn,
NFATC4	nuclear factor of activated T-cells 4(NFATC4)	Homo sapiens		h_bcrPathway:BCR Signaling Pathway,h_calcineurinPathway:Effects of calcineurin in Keratinocyte Differentiation,h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,h_fmlpPathway:fMLP induced chemokine gene expression in HMC-1 cells,h_gpcrPathway:Signaling Pathway from G-Protein Families,h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),h_tcrPathway:T Cell Receptor Signaling Pathway,		GO:0001569~patterning of blood vessels,GO:0006366~transcription from RNA polymerase II promoter,GO:0006954~inflammatory response,GO:0007507~heart development,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0030178~negative regulation of Wnt signaling pathway,GO:0032091~negative regulation of protein binding,GO:0032760~positive regulation of tumor necrosis factor production,GO:0033173~calcineurin-NFAT signaling cascade,GO:0034644~cellular response to UV,GO:0035562~negative regulation of chromatin binding,GO:0045333~cellular respiration,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048167~regulation of synaptic plasticity,GO:0050774~negative regulation of dendrite morphogenesis,GO:0051145~smooth muscle cell differentiation,GO:0055001~muscle cell development,GO:0071285~cellular response to lithium ion,GO:1902894~negative regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:2000297~negative regulation of synapse maturation,GO:2001235~positive regulation of apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0045111~intermediate filament cytoskeleton,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0042975~peroxisome proliferator activated receptor binding,	IPR002909:Cell surface receptor IPT/TIG,IPR008366:Nuclear factor of activated T cells (NFAT),IPR008967:p53-like transcription factor, DNA-binding,IPR011539:Rel homology domain,IPR013783:Immunoglobulin-like fold,IPR014756:Immunoglobulin E-set,	hsa04022:cGMP-PKG signaling pathway,hsa04310:Wnt signaling pathway,hsa04360:Axon guidance,hsa04921:Oxytocin signaling pathway,hsa05161:Hepatitis B,hsa05166:HTLV-I infection,			SM00429:IPT,	3D-structure,Activator,Alternative splicing,Complete proteome,Cytoplasm,Differentiation,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,	chain:Nuclear factor of activated T-cells, cytoplasmic 4,compositionally biased region:Pro-rich,domain:IPT/TIG,domain:RHD,modified residue,mutagenesis site,region of interest:2 approximate SP repeats,region of interest:Calcineurin-binding,repeat:SP 1,repeat:SP 2; approximate,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,strand,turn,
NCOR1	nuclear receptor corepressor 1(NCOR1)	Homo sapiens		h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),h_vdrPathway:Control of Gene Expression by Vitamin D Receptor,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007623~circadian rhythm,GO:0016569~covalent chromatin modification,GO:0044255~cellular lipid metabolic process,GO:0046329~negative regulation of JNK cascade,GO:0051225~spindle assembly,GO:0072362~regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,GO:0072368~regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,GO:1903799~negative regulation of production of miRNAs involved in gene silencing by miRNA,GO:2000191~regulation of fatty acid transport,	GO:0000118~histone deacetylase complex,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005876~spindle microtubule,GO:0016020~membrane,GO:0016580~Sin3 complex,GO:0017053~transcriptional repressor complex,	GO:0001102~RNA polymerase II activating transcription factor binding,GO:0003677~DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0016922~ligand-dependent nuclear receptor binding,GO:0035257~nuclear hormone receptor binding,GO:0042826~histone deacetylase binding,GO:0044212~transcription regulatory region DNA binding,GO:0046966~thyroid hormone receptor binding,	IPR001005:SANT/Myb domain,IPR009057:Homeodomain-like,IPR017884:SANT domain,	hsa04919:Thyroid hormone signaling pathway,hsa05202:Transcriptional misregulation in cancer,			SM00717:SANT,	3D-structure,Acetylation,Alternative splicing,Chromatin regulator,Coiled coil,Complete proteome,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:Nuclear receptor corepressor 1,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,domain:SANT 1,domain:SANT 2,helix,modified residue,region of interest:ID1,region of interest:ID2,region of interest:Interaction with C1D,region of interest:Interaction with ETO,region of interest:Interaction with SIN3A/B,region of interest:Interaction with ZBTB33 and HEXIM1,sequence conflict,short sequence motif:CORNR box 1,short sequence motif:CORNR box 2,short sequence motif:CORNR box 3,splice variant,
PTCH1	patched 1(PTCH1)	Homo sapiens		h_ptc1Pathway:Sonic Hedgehog (SHH) Receptor Ptc1 Regulates cell cycle,h_shhPathway:Sonic Hedgehog (Shh) Pathway,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001701~in utero embryonic development,GO:0001709~cell fate determination,GO:0001843~neural tube closure,GO:0003007~heart morphogenesis,GO:0007224~smoothened signaling pathway,GO:0007346~regulation of mitotic cell cycle,GO:0007420~brain development,GO:0008589~regulation of smoothened signaling pathway,GO:0009612~response to mechanical stimulus,GO:0009887~organ morphogenesis,GO:0009953~dorsal/ventral pattern formation,GO:0009957~epidermal cell fate specification,GO:0010157~response to chlorate,GO:0010875~positive regulation of cholesterol efflux,GO:0016485~protein processing,GO:0021522~spinal cord motor neuron differentiation,GO:0021532~neural tube patterning,GO:0021997~neural plate axis specification,GO:0030326~embryonic limb morphogenesis,GO:0032355~response to estradiol,GO:0032526~response to retinoic acid,GO:0032880~regulation of protein localization,GO:0035108~limb morphogenesis,GO:0035137~hindlimb morphogenesis,GO:0040015~negative regulation of multicellular organism growth,GO:0042493~response to drug,GO:0042593~glucose homeostasis,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0043616~keratinocyte proliferation,GO:0045606~positive regulation of epidermal cell differentiation,GO:0045668~negative regulation of osteoblast differentiation,GO:0045879~negative regulation of smoothened signaling pathway,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048568~embryonic organ development,GO:0050680~negative regulation of epithelial cell proliferation,GO:0051782~negative regulation of cell division,GO:0060037~pharyngeal system development,GO:0060603~mammary gland duct morphogenesis,GO:0060644~mammary gland epithelial cell differentiation,GO:0060831~smoothened signaling pathway involved in dorsal/ventral neural tube patterning,GO:0061005~cell differentiation involved in kidney development,GO:0061053~somite development,GO:0071397~cellular response to cholesterol,GO:0072001~renal system development,GO:0072203~cell proliferation involved in metanephros development,GO:0072661~protein targeting to plasma membrane,	GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005901~caveola,GO:0014069~postsynaptic density,GO:0016021~integral component of membrane,GO:0030496~midbody,GO:0030666~endocytic vesicle membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0044294~dendritic growth cone,GO:0044295~axonal growth cone,GO:0048471~perinuclear region of cytoplasm,GO:0060170~ciliary membrane,GO:0072372~primary cilium,	GO:0005113~patched binding,GO:0005119~smoothened binding,GO:0005515~protein binding,GO:0008158~hedgehog receptor activity,GO:0008201~heparin binding,GO:0015485~cholesterol binding,GO:0030332~cyclin binding,GO:0032403~protein complex binding,GO:0097108~hedgehog family protein binding,	IPR000731:Sterol-sensing domain,IPR003392:Patched,IPR004766:Transmembrane receptor, patched,	hsa04024:cAMP signaling pathway,hsa04340:Hedgehog signaling pathway,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05217:Basal cell carcinoma,	109400~Basal cell nevus syndrome,605462~Basal cell carcinoma, somatic,610828~Holoprosencephaly-7,			Alternative splicing,Complete proteome,Disease mutation,Glycoprotein,Holoprosencephaly,Isopeptide bond,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Transmembrane,Transmembrane helix,Tumor suppressor,Ubl conjugation,	chain:Protein patched homolog 1,compositionally biased region:Gly-rich,domain:SSD,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
PBRM1	polybromo 1(PBRM1)	Homo sapiens			Chromatin structure and dynamics / Transcription,	GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007067~mitotic nuclear division,GO:0008285~negative regulation of cell proliferation,GO:0016569~covalent chromatin modification,	GO:0000228~nuclear chromosome,GO:0005654~nucleoplasm,GO:0090544~BAF-type complex,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,	IPR001025:Bromo adjacent homology (BAH) domain,IPR001487:Bromodomain,IPR009071:High mobility group (HMG) box domain,IPR018359:Bromodomain, conserved site,				SM00297:BROMO,SM00398:HMG,SM00439:BAH,	3D-structure,Acetylation,Alternative splicing,Bromodomain,Chromatin regulator,Complete proteome,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Tumor suppressor,Ubl conjugation,	chain:Protein polybromo-1,compositionally biased region:Poly-Asp,compositionally biased region:Pro-rich,DNA-binding region:HMG box,domain:BAH 1,domain:BAH 2,domain:Bromo 1,domain:Bromo 2,domain:Bromo 3,domain:Bromo 4,domain:Bromo 5,domain:Bromo 6,helix,modified residue,sequence conflict,splice variant,turn,
PKD1L2	polycystin 1 like 2 (gene/pseudogene)(PKD1L2)	Homo sapiens				GO:0050982~detection of mechanical stimulus,GO:0070588~calcium ion transmembrane transport,	GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005262~calcium channel activity,GO:0005509~calcium ion binding,GO:0030246~carbohydrate binding,	IPR000203:GPS domain,IPR000922:D-galactoside/L-rhamnose binding SUEL lectin domain,IPR001024:Lipoxygenase, LH2,IPR001304:C-type lectin,IPR002859:PKD/REJ-like protein,IPR003915:Polycystic kidney disease type 2 protein,IPR013122:Polycystin cation channel, PKD1/PKD2,IPR014010:Egg jelly receptor, REJ-like,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,				SM00034:CLECT,SM00303:GPS,SM00308:LH2,	Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Ion channel,Ion transport,Lectin,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,	chain:Polycystic kidney disease protein 1-like 2,disulfide bond,domain:C-type lectin,domain:GPS,domain:PLAT,domain:REJ,domain:SUEL-type lectin,glycosylation site:N-linked (GlcNAc...),region of interest:Channel pore-region,region of interest:Interaction with GNAS and GNAI1,sequence conflict,sequence variant,short sequence motif:Polycystin motif,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
RMND5B	required for meiotic nuclear division 5 homolog B(RMND5B)	Homo sapiens			General function prediction only,	GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0034657~GID complex,	GO:0004842~ubiquitin-protein transferase activity,	IPR006594:LisH dimerisation motif,IPR006595:CTLH, C-terminal LisH motif,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013144:CRA domain,IPR024964:CTLH/CRA C-terminal to LisH motif domain,				SM00667:LisH,SM00668:CTLH,SM00757:CRA,	Acetylation,Alternative splicing,Complete proteome,Proteomics identification,Reference proteome,	chain:Protein RMD5 homolog B,domain:CTLH,domain:LisH,splice variant,
RTKN2	rhotekin 2(RTKN2)	Homo sapiens				GO:0007165~signal transduction,GO:0030097~hemopoiesis,			IPR001849:Pleckstrin homology domain,IPR011072:HR1 rho-binding repeat,IPR011993:Pleckstrin homology-like domain,IPR012966:Domain of unknown function DUF1709,				SM00233:PH,SM00742:Hr1,	Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Rhotekin-2,domain:PH,sequence variant,splice variant,
RPS6KA3	ribosomal protein S6 kinase A3(RPS6KA3)	Homo sapiens		h_gpcrPathway:Signaling Pathway from G-Protein Families,h_mapkPathway:MAPKinase Signaling Pathway,		GO:0001501~skeletal system development,GO:0002224~toll-like receptor signaling pathway,GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0007049~cell cycle,GO:0007165~signal transduction,GO:0007417~central nervous system development,GO:0030307~positive regulation of cell growth,GO:0032496~response to lipopolysaccharide,GO:0035556~intracellular signal transduction,GO:0043066~negative regulation of apoptotic process,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043555~regulation of translation in response to stress,GO:0043620~regulation of DNA-templated transcription in response to stress,GO:0045597~positive regulation of cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005840~ribosome,	GO:0000287~magnesium ion binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0019901~protein kinase binding,GO:0043027~cysteine-type endopeptidase inhibitor activity involved in apoptotic process,	IPR000719:Protein kinase, catalytic domain,IPR000961:AGC-kinase, C-terminal,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR016239:Ribosomal protein S6 kinase II,IPR017441:Protein kinase, ATP binding site,IPR017892:Protein kinase, C-terminal,	hsa04010:MAPK signaling pathway,hsa04114:Oocyte meiosis,hsa04150:mTOR signaling pathway,hsa04720:Long-term potentiation,hsa04722:Neurotrophin signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04931:Insulin resistance,	300844~Mental retardation, X-linked 19,303600~Coffin-Lowry syndrome,	PIRSF000606:ribosomal protein S6 kinase II,	SM00133:S_TK_X,SM00220:S_TKc,	3D-structure,ATP-binding,Cell cycle,Complete proteome,Cytoplasm,Disease mutation,Kinase,Magnesium,Mental retardation,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ribonucleoprotein,Ribosomal protein,Serine/threonine-protein kinase,Stress response,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Ribosomal protein S6 kinase alpha-3,domain:AGC-kinase C-terminal,domain:Protein kinase 1,domain:Protein kinase 2,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,
RNF111	ring finger protein 111(RNF111)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0007389~pattern specification process,GO:0016567~protein ubiquitination,GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway,GO:0030579~ubiquitin-dependent SMAD protein catabolic process,GO:0031398~positive regulation of protein ubiquitination,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0070911~global genome nucleotide-excision repair,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0043234~protein complex,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0032184~SUMO polymer binding,GO:0046332~SMAD binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,				SM00184:RING,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Isopeptide bond,Ligase,Metal-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase Arkadia,compositionally biased region:His-rich,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,region of interest:Interaction with AXIN1,sequence conflict,sequence variant,splice variant,zinc finger region:RING-type; atypical,
ROBO2	roundabout guidance receptor 2(ROBO2)	Homo sapiens				GO:0001656~metanephros development,GO:0001657~ureteric bud development,GO:0001822~kidney development,GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007411~axon guidance,GO:0007417~central nervous system development,GO:0007420~brain development,GO:0016199~axon midline choice point recognition,GO:0021510~spinal cord development,GO:0021891~olfactory bulb interneuron development,GO:0031290~retinal ganglion cell axon guidance,GO:0032870~cellular response to hormone stimulus,GO:0035385~Roundabout signaling pathway,GO:0050772~positive regulation of axonogenesis,GO:0050925~negative regulation of negative chemotaxis,GO:0051964~negative regulation of synapse assembly,GO:0061364~apoptotic process involved in luteolysis,	GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0030673~axolemma,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0008046~axon guidance receptor activity,GO:0042802~identical protein binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR009138:Neural cell adhesion,IPR013098:Immunoglobulin I-set,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,	hsa04360:Axon guidance,	610878~Vesicoureteral reflux 2,		SM00060:FN3,SM00406:IGv,SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Chemotaxis,Chromosomal rearrangement,Complete proteome,Developmental protein,Differentiation,Disease mutation,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Neurogenesis,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Roundabout homolog 2,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
SCLT1	sodium channel and clathrin linker 1(SCLT1)	Homo sapiens				GO:0042384~cilium assembly,GO:0045162~clustering of voltage-gated sodium channels,GO:0060271~cilium morphogenesis,	GO:0005813~centrosome,GO:0005814~centriole,GO:0005829~cytosol,GO:0070062~extracellular exosome,GO:0071439~clathrin complex,GO:0097539~ciliary transition fiber,	GO:0008022~protein C-terminus binding,GO:0017080~sodium channel regulator activity,GO:0030276~clathrin binding,						Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Sodium channel and clathrin linker 1,modified residue,sequence variant,splice variant,
SLC22A9	solute carrier family 22 member 9(SLC22A9)	Homo sapiens				GO:0009914~hormone transport,GO:0015698~inorganic anion transport,GO:0015913~short-chain fatty acid import,GO:0043252~sodium-independent organic anion transport,GO:0098656~anion transmembrane transport,	GO:0005887~integral component of plasma membrane,GO:0016323~basolateral plasma membrane,	GO:0005452~inorganic anion exchanger activity,GO:0015301~anion:anion antiporter activity,GO:0015347~sodium-independent organic anion transmembrane transporter activity,GO:0015636~short-chain fatty acid uptake transporter activity,	IPR011701:Major facilitator superfamily,IPR020846:Major facilitator superfamily domain,					Alternative splicing,Cell membrane,Complete proteome,Glycoprotein,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Solute carrier family 22 member 9,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
STAU2	staufen double-stranded RNA binding protein 2(STAU2)	Homo sapiens				GO:0006810~transport,	GO:0005730~nucleolus,GO:0005783~endoplasmic reticulum,GO:0005874~microtubule,GO:0016020~membrane,	GO:0003725~double-stranded RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR014720:Double-stranded RNA-binding-like domain,				SM00358:DSRM,	Alternative splicing,Complete proteome,Cytoplasm,Endoplasmic reticulum,Microtubule,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-binding,Transport,	chain:Double-stranded RNA-binding protein Staufen homolog 2,domain:DRBM 1,domain:DRBM 2,domain:DRBM 3,domain:DRBM 4,modified residue,region of interest:Required for dendritic transport,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal 1,short sequence motif:Nuclear localization signal 2,splice variant,
STAG2	stromal antigen 2(STAG2)	Homo sapiens			Cell division and chromosome partitioning,	GO:0007062~sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0016925~protein sumoylation,GO:0032876~negative regulation of DNA endoreduplication,GO:0051301~cell division,GO:0051321~meiotic cell cycle,	GO:0000775~chromosome, centromeric region,GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,GO:0016020~membrane,GO:0045111~intermediate filament cytoskeleton,	GO:0005515~protein binding,	IPR013721:STAG,IPR016024:Armadillo-type fold,IPR020839:Stromalin conservative domain,	hsa04110:Cell cycle,				3D-structure,Acetylation,Alternative splicing,Cell cycle,Cell division,Centromere,Chromosome,Chromosome partition,Coiled coil,Complete proteome,Meiosis,Mitosis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Cohesin subunit SA-2,compositionally biased region:Poly-Ser,domain:SCD,modified residue,sequence conflict,sequence variant,
SYCP2	synaptonemal complex protein 2(SYCP2)	Homo sapiens				GO:0007130~synaptonemal complex assembly,GO:0007140~male meiosis,GO:0007143~female meiotic division,GO:0009566~fertilization,GO:0043066~negative regulation of apoptotic process,GO:0048808~male genitalia morphogenesis,GO:0051301~cell division,	GO:0000795~synaptonemal complex,GO:0000800~lateral element,GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0046982~protein heterodimerization activity,	IPR024832:Synaptonemal complex protein 2,IPR024835:Synaptonemal complex protein 2/protein 2-like,					Cell cycle,Cell division,Chromosome,Complete proteome,DNA-binding,Meiosis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Synaptonemal complex protein 2,compositionally biased region:Poly-Ser,sequence conflict,sequence variant,
TET2	tet methylcytosine dioxygenase 2(TET2)	Homo sapiens				GO:0001822~kidney development,GO:0002318~myeloid progenitor cell differentiation,GO:0006211~5-methylcytosine catabolic process,GO:0006493~protein O-linked glycosylation,GO:0007049~cell cycle,GO:0009791~post-embryonic development,GO:0014070~response to organic cyclic compound,GO:0019511~peptidyl-proline hydroxylation,GO:0019857~5-methylcytosine metabolic process,GO:0019858~cytosine metabolic process,GO:0020027~hemoglobin metabolic process,GO:0030099~myeloid cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048536~spleen development,GO:0061484~hematopoietic stem cell homeostasis,GO:0070989~oxidative demethylation,GO:0072576~liver morphogenesis,GO:0080111~DNA demethylation,GO:0080182~histone H3-K4 trimethylation,	GO:0005634~nucleus,	GO:0000907~sulfonate dioxygenase activity,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008198~ferrous iron binding,GO:0008270~zinc ion binding,GO:0018602~2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity,GO:0019798~procollagen-proline dioxygenase activity,GO:0034792~hypophosphite dioxygenase activity,GO:0043734~DNA-N1-methyladenine dioxygenase activity,GO:0052634~C-19 gibberellin 2-beta-dioxygenase activity,GO:0052635~C-20 gibberellin 2-beta-dioxygenase activity,GO:0070579~methylcytosine dioxygenase activity,	IPR024779:2OGFeDO domain, nucleic acid-modifying type,		614286~Myelodysplastic syndrome, somatic,		SM01333:SM01333,	3D-structure,Alternative splicing,Cell cycle,Chromatin regulator,Complete proteome,Dioxygenase,DNA-binding,Glycoprotein,Iron,Metal-binding,Methylation,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Tumor suppressor,Zinc,	binding site:2-oxoglutarate,chain:Probable methylcytosine dioxygenase TET2,compositionally biased region:Gln-rich,compositionally biased region:Pro-rich,metal ion-binding site:Iron; catalytic,modified residue,sequence conflict,sequence variant,splice variant,
TCF7L2	transcription factor 7 like 2(TCF7L2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001568~blood vessel development,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007050~cell cycle arrest,GO:0007223~Wnt signaling pathway, calcium modulating pathway,GO:0008283~cell proliferation,GO:0009749~response to glucose,GO:0010909~positive regulation of heparan sulfate proteoglycan biosynthetic process,GO:0016055~Wnt signaling pathway,GO:0031016~pancreas development,GO:0032024~positive regulation of insulin secretion,GO:0032092~positive regulation of protein binding,GO:0032350~regulation of hormone metabolic process,GO:0042593~glucose homeostasis,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0043570~maintenance of DNA repeat elements,GO:0044334~canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,GO:0045444~fat cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046827~positive regulation of protein export from nucleus,GO:0048625~myoblast fate commitment,GO:0048660~regulation of smooth muscle cell proliferation,GO:0051897~positive regulation of protein kinase B signaling,GO:0060070~canonical Wnt signaling pathway,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:1904837~beta-catenin-TCF complex assembly,GO:2000675~negative regulation of type B pancreatic cell apoptotic process,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016605~PML body,GO:0032993~protein-DNA complex,GO:0070369~beta-catenin-TCF7L2 complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001103~RNA polymerase II repressing transcription factor binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0008134~transcription factor binding,GO:0019901~protein kinase binding,GO:0035257~nuclear hormone receptor binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0045295~gamma-catenin binding,GO:0070016~armadillo repeat domain binding,	IPR009071:High mobility group (HMG) box domain,IPR013558:CTNNB1 binding, N-teminal,IPR024940:Transcription factor TCF/LEF,IPR027397:Catenin binding domain,	hsa04310:Wnt signaling pathway,hsa04390:Hippo signaling pathway,hsa04520:Adherens junction,hsa04916:Melanogenesis,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05213:Endometrial cancer,hsa05215:Prostate cancer,hsa05216:Thyroid cancer,hsa05217:Basal cell carcinoma,hsa05221:Acute myeloid leukemia,hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),	125853~Diabetes mellitus, type 2, susceptibility to,		SM00398:HMG,	3D-structure,Activator,Alternative splicing,Complete proteome,Diabetes mellitus,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,Wnt signaling pathway,	chain:Transcription factor 7-like 2,compositionally biased region:Pro-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DNA-binding region:HMG box,helix,mutagenesis site,region of interest:CTNNB1-binding,region of interest:Promoter-specific activation domain,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,
TNRC6B	trinucleotide repeat containing 6B(TNRC6B)	Homo sapiens				GO:0007223~Wnt signaling pathway, calcium modulating pathway,GO:0031047~gene silencing by RNA,GO:0035194~posttranscriptional gene silencing by RNA,GO:0035278~miRNA mediated inhibition of translation,GO:0048015~phosphatidylinositol-mediated signaling,GO:0060213~positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,GO:1900153~positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,	GO:0000932~cytoplasmic mRNA processing body,GO:0005829~cytosol,	GO:0000166~nucleotide binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR012677:Nucleotide-binding, alpha-beta plait,IPR019486:Argonaute hook domain,					Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,RNA-mediated gene silencing,Translation regulation,	chain:Trinucleotide repeat-containing gene 6B protein,compositionally biased region:Gln-rich,compositionally biased region:Pro-rich,domain:RRM,modified residue,sequence conflict,sequence variant,splice variant,
TRIM17	tripartite motif containing 17(TRIM17)	Homo sapiens				GO:0006914~autophagy,GO:0032880~regulation of protein localization,GO:0051865~protein autoubiquitination,	GO:0005622~intracellular,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0030674~protein binding, bridging,GO:0046872~metal ion binding,	IPR000315:Zinc finger, B-box,IPR001841:Zinc finger, RING-type,IPR001870:B30.2/SPRY domain,IPR003877:SPla/RYanodine receptor SPRY,IPR003879:Butyrophylin-like,IPR006574:SPRY-associated,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR017907:Zinc finger, RING-type, conserved site,IPR027370:RING-type zinc-finger, LisH dimerisation motif,				SM00184:RING,SM00336:BBOX,SM00449:SPRY,SM00589:PRY,	Alternative splicing,Coiled coil,Complete proteome,Ligase,Metal-binding,Proteomics identification,Reference proteome,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase TRIM17,domain:B30.2/SPRY,zinc finger region:B box-type,zinc finger region:RING-type,
TP53	tumor protein p53(TP53)	Homo sapiens	1.RBphosphoE2F,152.altered_synaptic_signalling-neurodegenerative_disorders,157.14-3-3_Cell_Cycle,38.Cell_cycle_arrest_and_apoptosis_ceramide,94.E2F_transcriptional_activity_cell_cycle,99.NF-kB_activation,	h_arfPathway:Tumor Suppressor Arf Inhibits Ribosomal Biogenesis,h_atmPathway:ATM Signaling Pathway,h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,h_btg2Pathway:BTG family proteins and cell cycle regulation,h_chemicalPathway:Apoptotic Signaling in Response to DNA Damage,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,h_EfpPathway:Estrogen-responsive protein Efp controls cell cycle and breast tumors growth,h_g1Pathway:Cell Cycle: G1/S Check Point ,h_g2Pathway:Cell Cycle: G2/M Checkpoint,h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system,h_p53Pathway:p53 Signaling Pathway,h_plk3Pathway:Regulation of cell cycle progression by Plk3,h_pmlPathway:Regulation of transcriptional activity by PML,h_rbPathway:RB Tumor Suppressor/Checkpoint Signaling in response to DNA damage,h_rnaPathway:Double Stranded RNA Induced Gene Expression,h_telPathway:Telomeres, Telomerase, Cellular Aging, and  Immortality,h_tertPathway:Overview of telomerase protein component gene hTert Transcriptional Regulation ,h_tidPathway:Chaperones modulate interferon Signaling Pathway,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000733~DNA strand renaturation,GO:0006284~base-excision repair,GO:0006289~nucleotide-excision repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0006915~apoptotic process,GO:0006974~cellular response to DNA damage stimulus,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0006978~DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,GO:0006983~ER overload response,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0007265~Ras protein signal transduction,GO:0007275~multicellular organism development,GO:0007569~cell aging,GO:0008104~protein localization,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008340~determination of adult lifespan,GO:0010165~response to X-ray,GO:0010332~response to gamma radiation,GO:0010628~positive regulation of gene expression,GO:0016032~viral process,GO:0016925~protein sumoylation,GO:0030154~cell differentiation,GO:0030308~negative regulation of cell growth,GO:0030330~DNA damage response, signal transduction by p53 class mediator,GO:0031065~positive regulation of histone deacetylation,GO:0031497~chromatin assembly,GO:0031571~mitotic G1 DNA damage checkpoint,GO:0032461~positive regulation of protein oligomerization,GO:0034613~cellular protein localization,GO:0034644~cellular response to UV,GO:0035690~cellular response to drug,GO:0042149~cellular response to glucose starvation,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043153~entrainment of circadian clock by photoperiod,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043525~positive regulation of neuron apoptotic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046677~response to antibiotic,GO:0046827~positive regulation of protein export from nucleus,GO:0046902~regulation of mitochondrial membrane permeability,GO:0048147~negative regulation of fibroblast proliferation,GO:0048512~circadian behavior,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0051097~negative regulation of helicase activity,GO:0051262~protein tetramerization,GO:0051974~negative regulation of telomerase activity,GO:0070245~positive regulation of thymocyte apoptotic process,GO:0071158~positive regulation of cell cycle arrest,GO:0071456~cellular response to hypoxia,GO:0071479~cellular response to ionizing radiation,GO:0072332~intrinsic apoptotic signaling pathway by p53 class mediator,GO:0090200~positive regulation of release of cytochrome c from mitochondria,GO:0090399~replicative senescence,GO:0090403~oxidative stress-induced premature senescence,GO:0097193~intrinsic apoptotic signaling pathway,GO:0097252~oligodendrocyte apoptotic process,GO:1900119~positive regulation of execution phase of apoptosis,GO:1900740~positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,GO:1901796~regulation of signal transduction by p53 class mediator,GO:1902749~regulation of cell cycle G2/M phase transition,GO:1990440~positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,GO:2000379~positive regulation of reactive oxygen species metabolic process,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005657~replication fork,GO:0005669~transcription factor TFIID complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0016363~nuclear matrix,GO:0016604~nuclear body,GO:0016605~PML body,GO:0043234~protein complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001046~core promoter sequence-specific DNA binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0002020~protease binding,GO:0002039~p53 binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003684~damaged DNA binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005507~copper ion binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0019903~protein phosphatase binding,GO:0030971~receptor tyrosine kinase binding,GO:0031625~ubiquitin protein ligase binding,GO:0035035~histone acetyltransferase binding,GO:0042802~identical protein binding,GO:0043565~sequence-specific DNA binding,GO:0043621~protein self-association,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,GO:0047485~protein N-terminus binding,GO:0051087~chaperone binding,GO:0051721~protein phosphatase 2A binding,	IPR002117:p53 tumour suppressor family,IPR008967:p53-like transcription factor, DNA-binding,IPR010991:p53, tetramerisation domain,IPR011615:p53, DNA-binding domain,IPR012346:p53/RUNT-type transcription factor, DNA-binding domain,IPR013872:p53 transactivation domain,IPR015155:PLAA family ubiquitin binding, PFU,	hsa04010:MAPK signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04110:Cell cycle,hsa04115:p53 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04210:Apoptosis,hsa04310:Wnt signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa05014:Amyotrophic lateral sclerosis (ALS),hsa05016:Huntington's disease,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05162:Measles,hsa05166:HTLV-I infection,hsa05168:Herpes simplex infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05203:Viral carcinogenesis,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05210:Colorectal cancer,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05216:Thyroid cancer,hsa05217:Basal cell carcinoma,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,	114480~Breast cancer,114500~Colorectal cancer,114550~Hepatocellular carcinoma,137800~Glioma susceptibility 1,151623~Li-Fraumeni syndrome,202300~Adrenal cortical carcinoma,259500~Osteosarcoma,260350~Pancreatic cancer,260500~Choroid plexus papilloma,607107~Nasopharyngeal carcinoma,614740~Basal cell carcinoma 7,			3D-structure,Acetylation,Activator,Alternative promoter usage,Alternative splicing,Apoptosis,Biological rhythms,Cell cycle,Complete proteome,Cytoplasm,Disease mutation,DNA-binding,Endoplasmic reticulum,Glycoprotein,Host-virus interaction,Isopeptide bond,Li-Fraumeni syndrome,Membrane,Metal-binding,Methylation,Mitochondrion,Necrosis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,somatic,Transcription,Transcription regulation,Transmembrane,Transmembrane helix,Tumor suppressor,Ubl conjugation,Zinc,ZincFT   VARIANT     247    248       NR -> KW (in sporadic cancers,	chain:Cellular tumor antigen p53,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),helix,metal ion-binding site:Zinc,modified residue,mutagenesis site,region of interest:Basic (repression of DNA-binding),region of interest:Interaction with AXIN1,region of interest:Interaction with CARM1,region of interest:Interaction with E4F1,region of interest:Interaction with HIPK1,region of interest:Interaction with HIPK2,region of interest:Interaction with HRMT1L2,region of interest:Interaction with USP7,region of interest:Interaction with WWOX,region of interest:Interacts with the 53BP2 SH3 domain,region of interest:Oligomerization,region of interest:Required for interaction with FBXO42,region of interest:Transcription activation (acidic),sequence variant,short sequence motif:[KR]-[STA]-K motif,short sequence motif:Bipartite nuclear localization signal,short sequence motif:Nuclear export signal,splice variant,strand,turn,
USP28	ubiquitin specific peptidase 28(USP28)	Homo sapiens				GO:0000077~DNA damage checkpoint,GO:0006281~DNA repair,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006974~cellular response to DNA damage stimulus,GO:0007265~Ras protein signal transduction,GO:0008283~cell proliferation,GO:0010212~response to ionizing radiation,GO:0016579~protein deubiquitination,GO:0031647~regulation of protein stability,GO:0034644~cellular response to UV,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0043234~protein complex,	GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0005515~protein binding,GO:0036459~thiol-dependent ubiquitinyl hydrolase activity,	IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2,IPR009060:UBA-like,IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site,					3D-structure,Alternative splicing,Coiled coil,Complete proteome,DNA damage,DNA repair,Hydrolase,Nucleus,Phosphoprotein,Protease,Proteomics identification,Reference proteome,Thiol protease,Ubl conjugation pathway,	chain:Ubiquitin carboxyl-terminal hydrolase 28,modified residue,repeat:UIM,sequence conflict,splice variant,
USP35	ubiquitin specific peptidase 35(USP35)	Homo sapiens				GO:0006511~ubiquitin-dependent protein catabolic process,GO:0016579~protein deubiquitination,		GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0036459~thiol-dependent ubiquitinyl hydrolase activity,	IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2,IPR016024:Armadillo-type fold,IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site,					Alternative splicing,Coiled coil,Complete proteome,Hydrolase,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,Thiol protease,Ubl conjugation pathway,	chain:Ubiquitin carboxyl-terminal hydrolase 35,modified residue,sequence variant,
USP43	ubiquitin specific peptidase 43(USP43)	Homo sapiens				GO:0006511~ubiquitin-dependent protein catabolic process,GO:0016579~protein deubiquitination,GO:0019985~translesion synthesis,	GO:0005654~nucleoplasm,	GO:0019785~ISG15-specific protease activity,GO:0036459~thiol-dependent ubiquitinyl hydrolase activity,	IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2,IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site,					Alternative splicing,Complete proteome,Hydrolase,Methylation,Phosphoprotein,Protease,Proteomics identification,Reference proteome,Thiol protease,Ubl conjugation pathway,	chain:Ubiquitin carboxyl-terminal hydrolase 43,modified residue,sequence conflict,splice variant,
XYLT2	xylosyltransferase 2(XYLT2)	Homo sapiens				GO:0006024~glycosaminoglycan biosynthetic process,GO:0015012~heparan sulfate proteoglycan biosynthetic process,GO:0030206~chondroitin sulfate biosynthetic process,GO:0030210~heparin biosynthetic process,GO:0050650~chondroitin sulfate proteoglycan biosynthetic process,	GO:0000139~Golgi membrane,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0008375~acetylglucosaminyltransferase activity,GO:0030158~protein xylosyltransferase activity,	IPR003406:Glycosyl transferase, family 14,IPR024448:Xylosyltransferase,	hsa00532:Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate,hsa00534:Glycosaminoglycan biosynthesis - heparan sulfate / heparin,hsa01100:Metabolic pathways,	264800~Pseudoxanthoma elasticum, modifier of severity of,605822~Spondyloocular syndrome,			Alternative splicing,Complete proteome,Disease mutation,Disulfide bond,Endoplasmic reticulum,Glycoprotein,Glycosyltransferase,Golgi apparatus,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Xylosyltransferase 2,glycosylation site:N-linked (GlcNAc...),sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ZC3H13	zinc finger CCCH-type containing 13(ZC3H13)	Homo sapiens					GO:0005654~nucleoplasm,GO:0016021~integral component of membrane,GO:0016607~nuclear speck,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000571:Zinc finger, CCCH-type,				SM00356:ZnF_C3H1,	Alternative splicing,Coiled coil,Complete proteome,Isopeptide bond,Membrane,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger CCCH domain-containing protein 13,compositionally biased region:Arg/Glu-rich,compositionally biased region:Arg/Ser-rich,compositionally biased region:Lys-rich,compositionally biased region:Ser-rich,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:C3H1-type,
ZC3H18	zinc finger CCCH-type containing 18(ZC3H18)	Homo sapiens					GO:0005654~nucleoplasm,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000571:Zinc finger, CCCH-type,				SM00356:ZnF_C3H1,	Acetylation,Alternative splicing,Coiled coil,Complete proteome,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger CCCH domain-containing protein 18,compositionally biased region:Poly-Asp,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:C3H1-type,
ZNF292	zinc finger protein 292(ZNF292)	Homo sapiens				GO:0006366~transcription from RNA polymerase II promoter,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 292,helix,modified residue,sequence conflict,strand,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ZNF750	zinc finger protein 750(ZNF750)	Homo sapiens				GO:0006366~transcription from RNA polymerase II promoter,GO:0008544~epidermis development,GO:0030154~cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0043231~intracellular membrane-bounded organelle,	GO:0001046~core promoter sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0005515~protein binding,GO:0046872~metal ion binding,			610227~Seborrhea-like dermatitis with psoriasiform elements,			Activator,Complete proteome,Differentiation,Metal-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Protein ZNF750,sequence conflict,sequence variant,
ZFPM1	zinc finger protein, FOG family member 1(ZFPM1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002295~T-helper cell lineage commitment,GO:0003151~outflow tract morphogenesis,GO:0003181~atrioventricular valve morphogenesis,GO:0003192~mitral valve formation,GO:0003195~tricuspid valve formation,GO:0006351~transcription, DNA-templated,GO:0007507~heart development,GO:0007596~blood coagulation,GO:0010724~regulation of definitive erythrocyte differentiation,GO:0030218~erythrocyte differentiation,GO:0030219~megakaryocyte differentiation,GO:0030220~platelet formation,GO:0030851~granulocyte differentiation,GO:0032091~negative regulation of protein binding,GO:0032642~regulation of chemokine production,GO:0035162~embryonic hemopoiesis,GO:0035855~megakaryocyte development,GO:0045078~positive regulation of interferon-gamma biosynthetic process,GO:0045403~negative regulation of interleukin-4 biosynthetic process,GO:0045599~negative regulation of fat cell differentiation,GO:0055008~cardiac muscle tissue morphogenesis,GO:0060318~definitive erythrocyte differentiation,GO:0060319~primitive erythrocyte differentiation,GO:0060377~negative regulation of mast cell differentiation,GO:0060412~ventricular septum morphogenesis,GO:0060413~atrial septum morphogenesis,GO:0071733~transcriptional activation by promoter-enhancer looping,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0017053~transcriptional repressor complex,	GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	3D-structure,Activator,Complete proteome,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein ZFPM1,modified residue,region of interest:Interaction with CTBP2,region of interest:Interaction with TACC3,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2HC-type 1,zinc finger region:C2HC-type 2,zinc finger region:C2HC-type 3,zinc finger region:C2HC-type 4,zinc finger region:C2HC-type 5,
